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ABSTRACT
The idea that adrenal secretions can influence the repro¬
ductive system has been the subject of a great deal of research
effort that spans the last three decades. These basic experiments
employed indices of fertility and sexual function as relatively
crude end-points for investigation whilst others concentrated on
the effects of stress to implicate a role for the adrenal gland in
reproduction. However, the introduction of specific radio¬
immunoassays for steroids in blood and the development of isolated
cell technology have permitted new and powerful tools with which to
investigate this intriguing problem.
The aim of this thesis is to investigate the mechanisms by
which the adrenal gland may influence testicular steroidogenesis in
the male rat. The present study has employed and adapted specific
radioimmunoassays for progesterone, corticosterone and testosterone
for use in rat plasma in addition these assays as well as those
for 17cA-hydroxyprogesterone and androstenedione, for use in in
vitro isolated cell studies. Furthermore, the development of a
reproducible isolated-cell superfusion technique has allowed this
study to focus on possible direct interactions between the steroid-
secreting cells of the adrenal and the testis.
The administration of pharmacological doses of glucocorticoid
to male rats in vivo not only suppresses adrenal steroidogenesis
but also inhibits testicular steroidogenesis by inhibiting the
anterior pituitary secretion of LH. In contrast, stimulation of
the adrenal gland by the administration of ACTH to these
pharmacologically-suppressed rats stimulates the adrenal secretion
of progesterone and testicular steroidogenesis. The mechanism by
which ACTH increases testicular steroidogenesis is dependent on the
presence of the adrenal gland and its secretion of progesterone.
This thesis draws upon existing evidence of the common elements in
adrenal and testicular steroidogenesis and demonstrates that common
steroid precursors secreted by the adrenal can be utilised by the
testis in the synthesis and secretion of testosterone.
Furthermore, the in vitro juxtaposition of ACTH-stimulated
isolated adrenal cells with isolated testicular cells results in
increased secretion of testosterone and this effect is dependent
upon the adrenal secretion of progesterone.
The overwhelming conclusion from these data is that the
adrenal gland has an important role in generating external signals
that modulate the hypothalamic-pituitary-gonadal axis in male rats.
The adrenal secretion of glucocorticoid acts as a negative signal
to testicular steroidogenesis whereas progesterone acts as a
positive signal. The adrenal secretion of progesterone and its
conversion to testosterone by steroidogenic enzymes in the
cytoplasm of the Leydig cell may provide an alternative pathway for
testosterone biosynthesis and may account for the increased plasma
testosterone levels during the acute phase of stress and mating.
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1.1: The aim of the thesis
The experiments described in this thesis are designed to
demonstrate that the adrenocortical secretion of steroid hormones
can, either directly or indirectly, modify the testicular secretion
of testosterone in the rat.
The idea that adrenal secretions can affect the reproductive
system has been the subject of a great deal of research effort
since the 1950s (for review see Ramaley, 1974). Evidence that the
adrenal gland can influence gonadal relationships, in both sexes,
in terms of the development of puberty and sexual maturation
(Ramaley, 1974; Meijs-Roelofs, 1978) and gonadal function in
general (Andrews, 1977; Kime, 1981) has been extensively reviewed.
The experimental approaches employed for the study of adrenal »
gonadal interactions have been various. However, this concept has
not been widely accepted, primarily because much of the evidence
has been indirect. Many of these basic experiments employed
indices of fertility and sexual function as relatively crude end-
points for investigation, namely the induction of puberty,
ovulation, conception, fetal wastage and lactation. Other reviews
have concentrated on the effects of stress upon the reproductive
system to implicate a role for the adrenal gland in reproduction
(Andrews, 1977). From the results of these experiments it is
reasonable to argue that the adrenal gland may have an effect upon
gonadal function. However, the mechanism(s) by which the adrenal
gland may influence gonadal function has not been determined.
There is clearly scope for further investigation and the purpose of
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this thesis is to investigate the possible influence of the adrenal
gland upon testicular steroidogenesis in the rat.
This chapter will review the pathways and regulation of
adrenocortical and testicular steroidogenesis, the common elements
in these pathways in adrenal and gonadal tissues, and previous
studies to date that have implicated a role for adrenocortical
steroids in the regulation of testicular steroidogenesis in the
rat.
'There can be few more reliable methods of alienating the
interest of a scientific or medical audience than by presenting the
formulae of half-a-dozen steroid compounds. Perhaps it is the
asymmetry of the steroid skeleton or the fact that closely related
structures may represent compounds with greatly different chemical,
biochemical and physical properties that induces the sense of
frustration. This response is quite commonplace, but those who
follow the few simple rules and conventions will discover in the
steroid group the most orderly and rational arrangement of
compounds of any group in the biochemical field; they will have
joined the select group for whom the cyclopentanoperhydro-
phenanthrene skeleton has no terrors'.
(Kellie, 1984)
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Fortunately, steroidogenesis in the rat adrenal cortex and
testis is relatively simple, when compared with other mammalian
counterparts (for review see Peron, 1968; Chubb, 1979b).
1.2; The Adrenal Cortex
1.2.1: Historical perspectives
The adrenal glands were noted for the first time in 1563 when
Bartholomaeus Eustachius named them as 'Glandulae Renibus
incumbentes'. However, it was not until 1714 that Eustachius'
drawings of human anatomy were first published by Lancisius who
named the adrenal glands 'Renes-succenturiati ab Eustachio primum
detecti1. Although other names occurred over the ensuing years it
was Jean Riolan the younger who introduced the familiar term
'suprarenal capsule' in 1629. The division between the medulla and
cortex was recognised by Cuvier in 1805 but the actual terms
'medulla' and 'cortex' were not introduced until 1854 by Hushke,
Kolliker and Gray. The use of the term 'adrenal' by Huxley and
Martin finally emerged in 1875 (source, Chester Jones, 1976).
1.2.2: Adrenocortical structure and function
In 1858 Harley first described the divisions of the human
adrenal cortex into three distinct zones - glomerulosa, fasciculata
and reticularis. Over the years information from animal and human
studies has established that cells of the zona glomerulosa secrete
aldosterone (Ayres, 1956) but studies suggesting a clear separation
of structure and function in the zonas fasciculata and reticularis
4
are somewhat lacking (Bell, 1978; Bell 1980; Maroulis, 1980). Any
differences that may exist in the secretion of glucocorticoid and
androgen from human adrenal zona fasciculata and reticularis cells
appear to be quantitative rather than qualitative (Maroulis, 1980).
However, since the rat adrenal cortex is unable to secrete
significant amounts of either androgen or Cortisol, and, since the
synthesis of the major glucocorticoid, corticosterone, involves the
mineralocorticoid (aldosterone) pathway (for review see Sandor,
1976), perhaps these arguments do not concern us.
1.2.3: Adrenocortical steroidogenesis
The adrenal cortex is the target tissue for the peptide
hormone ACTH which is secreted by the anterior pituitary gland.
The initial event in the action of ACTH is its binding to specific
receptor sites on the membrane of the adrenal cell. This is
followed by the activation of adenylate cyclase and the production
of S'^'-cyclic AMP (cAMP), which in turn activates protein kinase
resulting in phosphorylation of the enzyme cholesterol ester
hydrolase. The active cholesterol ester hydrolase catalyses the
hydrolysis of stored cholesterol esters increasing the availability
of free cholesterol to the mitochondria and its enzyme cytochrome
P-450 side chain cleavage. In addition the binding of ACTH to its
receptor also causes an increase in the synthesis of membrane
phospholipids and the mobilisation of intracellular calcium, both
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Figure 1.1: The major pathways of steroidogenesis in steroid
secreting tissues. The enzymes involved in steroid synthesis are:
(1) cholesterol desmolase complex; (2) 3^-hydroxysteroid
dehydrogenase/isomerase complex; (3) 17A-hydroxylase; (4) 17,22-
desmolase; (5) 21-hydroxylase; (6) 1^-hydroxylase; (7) 18-
hydroxylase; (8) 11-hydroxysteroid dehydrogenase (9) 17jJ-
hydroxysteroid oxidoreductase; (10) aromatase; (11) 5iA-reductase;
(12) sulphate conjugase (redrawn from Dewis, 1983).
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genesis. The main corticosteroids secreted by the adrenal eortex
are:
i) Glucocorticoids - Cortisol and corticosterone.
ii) Mineralocorticoids - aldosterone.
iii) Sex steroids - a complex group consisting of the
androgens (testosterone, dehydroepiandrosterone and its sulphate,
and androstenedione), the oestrogens (oestradiol and oestrone) and
the progestagens (progesterone). The possible biosynthetic
pathways for these adrenocortical steroids are illustrated in
figure 1.1. However, the principal steroids secreted by the rat
adrenal cortex are 11-deoxycorticosterone, corticosterone, 18-
hydroxycorticosterone and aldosterone (for review see Sandor,
1976). In the rat, steroidogenesis is therefore inhibited in the
following pathways (Peron, 1968; Sandor, 1976):
i) 17,20-desmolase: 17<A-hydroxypregnenelone ► dehydro¬
epiandrosterone » dehydroepiandrosterone sulphate.
ii) 17,20-desmolase: 17c\-hydroxyprogesterone » andro¬
stenedione testosterone.
iii) 21-hydroxylase: 17<*-hydroxyprogesterone » 11-deoxy-
cortisol » Cortisol.
The rat adrenal cortex does not appear to secrete significant
amounts of either sex steroid or Cortisol. The two main products
of steroidogenesis in the rat are corticosterone as the gluco¬
corticoid, and aldosterone as the mineralocortieoid. Nevertheless,
it has been claimed that the rat adrenal may secrete Cortisol
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androstenedione (Vinson, 1976; Bell, 1978) and testosterone
(Vinson, 1976). However, evidence for I7-hydroxylation in the rat
adrenal cortex remains controversial.
The pathways of rat adrenal steroidogenesis are illustrated in
figure 1.2. It will be seen that steroidogenesis takes place in
two compartments - the mitochondria and the cytoplasmic endoplasmic
reticulum. The pathway from cholesterol through to corticosterone
and aldosterone involves steroid hydroxylases which are different
forms of cytochrome P-450. These enzymes catalyse the reaction
whereby one atom of oxygen is added to the substrate, yielding an
hydroxylated product, whilst the other atom of oxygen is used to
form water. Cytochrome P-450 is a diverse and large family of
enzymes bound to membranes of the mitochondria and endoplasmic
reticulum. The conversion of cholesterol to pregnenelone
(cholesterol side-chain cleavage) takes place in the mitochondria
and, whilst the subject of this conversion has attracted some
controversy, the details are not essential for the understanding of
this thesis (for review see Simpson, 1979).
Following the mitochondrial synthesis of pregnenelone, its
subsequent metabolism is carried out by the endoplasmic reticulum
by the conversion of pregnenelone:
i) 17-hydroxylase: pregnenelone » TJX-hydroxypregnenelone
» (3^-hydroxysteroid dehydrogenase plus isomerase) 17^-hydroxy-
progesterone.
ii) 3J3-hydroxysteroid dehydrogenase plus isomerase:
pregnenelone » progesterone » (17-hydroxylase) 17j?(—
9
hydroxyprogesterone.
The final pathway of adrenal steroidogenesis involves the
conversion of progesterone:
i) 21-hydroxylase: progesterone » 11-deoxycorticosterone
> (11-hydroxylase) corticosterone » 18-hydroxycorticosterone
» (18-hydroxylase) aldosterone.
The activity of both the enzymes, 11-hydroxylase and 18-
hydroxylase, resides in the mitochondrion and not in the endo¬
plasmic reticulum, so that adrenal steroidogenesis switches back
from the cytoplasm to the mitochondria for the synthesis of
corticosterone and aldosterone.
Whether the intermediary metabolites of adrenocortical
steroidogenesis have any function as hormones in their own right or
whether they are unnecessary by-products of steroidogenesis is open
to question (Short, 1960). For example, the adrenal secretion of
androstenedione has been proposed as a prehormone in the human
(Baird, 1968). Can a similar role be ascribed for adrenal steroid
precursors in the male rat? The adrenocortical synthesis of
precursor steroids such as progesterone and their subsequent
secretion into the circulation may be the basis for direct adrenal
» gonad interaction, by providing the testis with metabolic
substrates that can be used in the synthesis and secretion of
testosterone.
For this to occur, it must be generally accepted that steroids
can freely leave the adrenal gland, enter the circulation and enter
the testis. There is a presumption that all steroids leave and
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enter cells freely at identical rates (Sandor, 1976). This
presumption has recently been tested by systematic experiments on
the diffusional behaviour of different steroids through cell
membranes (Giorgi, 1981). Velocity of passage of free steroids
across plasma membranes is probably passive (simple diffusion) and
the coefficient of diffusion is directly related to its partition
coefficient in n-octanol. Thus, progesterone being a non-polar
in water
steroid with a high partition coefficient (124) in n-octano^, it
has a high permeability coefficient (3.9 x 10-^ cm sec~^) across
plasma lipid membranes when compared with corticosterone (partition
coefficient 46 and permeability coefficient 0.99 x 10-i* cm sec-^)
and will therefore leave adrenal cells and enter testicular cells
with relative ease when compared with other steroids. Furthermore,
not all steroids pass through membranes of subcellular organelles
with the same ease (Vinson, 1969a; Vinson, 1969b; Vinson, 1970).
Thus, the mitochondrion may act as a barrier to the passage of some
steroids so that the administration of exogenous steroids from a
biosynthetic pathway may not necessarily stimulate steroidogenesis.
1.2.4: Methodology for the study of adrenocortical steroidogenesis
Removal of adrenal tissue and manipulation under isolated
conditions gives in vitro results which, with due caution, can be
related to in vivo conditions. However, qualification of this
statement is necessary, because results obtained in vitro may
differ from those obtained in vivo (Vinson, 1971)• The rat is an
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ideal experimental animal providing an easily accessible and
readily abundant supply of tissue but has the disadvantage of being
so far removed from the human adrenal as to make comparisons
difficult. For the practising physician in endocrinology, this
barrier may at first appear insurmountable, yet this animal has
provided a wealth of information on a wide and varying number of
physiological conditions. This animal should at least help our
understanding of the influence of adrenal gland upon testicular
steroidogenesis.
The rat adrenal has been subjected to a wide variety of
procedures involving either:
i) static incubations of isolated whole uncut adrenals
(Stachenko, 1971), tissue slices (Saffran, 1953; Laplante, 1966),
minced whole glands (Vinson, 1969a; Vinson 1969b), and isolated
cells (Kloppenborg, 1968).
ii) superfusion of adrenals (Orti, 1965; Tait, 1967) and
isolated cells (Lowry, 1974).
iii) perfusion of the isolated whole organ (Sibley, 1981).
Next to in vivo experiments and whole organ perfusions,
continuous superfusion of isolated adrenal cells is probably the
most physiologically relevant (Sandor, 1976).
In vitro cell suspensions are prepared by digestion of minced
or quartered adrenal tissue with either trypsin or collagenase,
followed by gentle mechanical dispersion achieved by repeated
pipetting of the tissue (Haning, 1970). The resulting cell
suspension of mixed adrenocortical cells produces low basal levels
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of steroid that have increased sensitivity to ACTH when compared
with other in vivo or in vitro techniques employed for bioassay
(Kloppenborg, 1968). Both collagenase and trypsin have been used
as the enzyme to digest adrenal tissue. When collagenase is
employed, a crude preparation of the enzyme is used, because
purified forms are largely ineffective (Kono, 1969). In contrast,
trypsin is active in its purified form (Sayers, 1971), but has the
disadvantage of being abrasive (Kono, 1971) and also requires
reversal of its activity with trypsin inhibitor (Al-Dujaili, 1982)
in order to prevent increased loss of cell surface receptors
(Sayers, 1971). Furthermore, it has been recently demonstrated
that trypsin (Raven, 1982) and its inhibitors (Pedersen, 1983;
Raven, 1983) may have direct and profound effects upon adrenal
steroidogenesis. For these reasons collagenase is preferred by
many workers.
Following enzyme dispersion, zona reticularis and zona
glomerulosa cells have a similar appearance by light microscopy.
In contrast, zona fasciculata cells are larger (twice the
diameter), with an increased cytoplasmic nuclear ratio and
increased lipid content when compared with their reticularis
counterparts (Bell, 1980). By electron microscopy, zona
glomerulosa cells have tubular, zona fasciculata cells can be seen
to have spherical and zona reticularis have mixed tubular/spherical
mitochondrial cristae. Zona glomerulosa cells may be separated
from zona fasciculata and reticularis cells by decapsulation of the
whole adrenal gland prior to enzyme digestion. Isolated
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populations of reticularis and fasciculata cells may then be
separated by unit gravity sedimentation after digestion of the
decapsulated gland. Using this method it has not been possible to
demonstrate qualitative differences in steroid production by the
two populations. However, quantitatively there is reduced 11-
hydroxylation in the reticularis layer (Bell, 1980).
Dispersed adrenocortical cells are usually incubated in Krebs-
Ringer buffer with glucose and albumen, either in static incubation
or in a continuous superfusion system. Proponents of superfusion
technology point out that in static incubations products remain in
the medium and may alter secretion rates or be processed to
abnormal end-products. Superfusion overcomes some of these
problems and provides a system for the dynamic study of adrenal
steroidogenesis. In general, steroid output is higher in the
superfusion than the static system. This is in keeping with the
observation that corticosterone is passively secreted and therefore
sensitive to changes in the flow or volume of incubation medium
(Sibley, 1980; Sibley, 1981).
Because these studies employ cells derived from enzymatically
digested whole adrenal tissues, it is necessary to consider what
effect enzymes of the adrenal medulla may have upon steroidogenesis
of the adrenal cortex. Steroid hydroxylases have been demonstrated
in phaeochromocytomas and in beef adrenal medulla slices
(Carballeira, 1965) but studies performed in the rat show that
adrenal medulla plays an insignificant role in steroid
hydroxylation (Peron, 1968).
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1.2.5: The hypothalamic-pituitary-adrenal axis
1.2.5-1.: Biochemistry and physiology of ACTH-related peptides
Anterior pituitary corticotrophin cells secrete ACTH as part
of a precursor molecule, pro-opiomelanocortin (POMC) (Mains, 1977;
Roberts, 1977). The sequence for bovine POMC consists of three
peptides: ACTH, {3-lipotrophin (p~LPH) and an N-terminal sequence,
N-POMC, preceded by a signal peptide (Nakanishi, 1979). Human N-
POMC consists of a peptide of 76 amino acids with an apparent
molecular weight by gel filtration of 11200. In man, N-POMC-j_yg is
the main secretory form of the N-terminal peptide (Estivariz, 1980)
and the sequence N-POMCYq_-|09 is the connecting peptide between N-
POMC-|_75 and ACTH (Seidah, 1981). N-POMC is secreted with ACTH and
J3-LPH under a wide range of physiological and pathological
conditions.
The availability of purified N-POMC has made possible the
production of specific radioimmunoassays against different parts of
the sequence (Hope, 1981). All three peptides derived from POMC
are secreted concomitantly into the circulation and their concen¬
tration in plasma increases after adrenalectomy and becomes
undetectable after hypophysectomy (Lis, 1982). Concomitant
secretion of these three products is stimulated by corticotrophin
releasing factor (CRF) and inhibited by dexamethasone (Oki, 1982).
Hope (1981) observed a close correlation between plasma concen¬
trations of N-POMC and ACTH reflecting co-ordinated synthesis and
secretion in vivo. Studies with rat pituitary corticotrophs
in vitro indicate that the three peptides are secreted in equimolar
15
concentrations, reflecting post-translational cleavage of the
parent molecule, POMC.
The amino acid sequence His-Phe-Arg-Trp encoded within the N-
terminal portion of POMC is also shared by the melanotrophins«*-
and fS-MSH encoded within the peptides ACTH and |3-LPH respectively.
Smaller peptides containing the sequences of N-POMC5"|_5i (y-|-MSH),
N-P0MC5-]_52 and N-POMC5i_76 (Jf^-MSH) have been synthesised
and used in the development of radioimmunoassays (Ling, 1979).
The species similarity of the three products of POMC suggests
a related biological function. Although the biological actions of
ACTH are well-established, at least in regard to the adrenal gland,
no definite function for p-LPH and N-POMC has been determined. The
observation that the first five residues of ^-endorphin are common
with the opiate peptide Met-enkephalin led to the discovery of its
potent opiate-like activity (Li, 1977). However, despite intensive
research on the matter, no clear role for an adrenal or extra-
adrenal action of J3-LPH/{3-endorphin has emerged.
Interestingly, POMC is not only confined to the anterior
pituitary but is also to be found in the central nervous system,
placenta, and gastrointestinal tract (for review see Bardin, 1984).
POMC peptides are also to be found in testicular Leydig cells and
are processed in a similar manner to the anterior pituitary.
Peptides derived from POMC are present in the testis during fetal
life and following puberty, when testosterone secretion is maximal.
Furthermore, the amount of testicular POMC increases with the
administration of LH or hCG. Derivatives of POMC, ACTH or MSH
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stimulate the growths/and accumulation of cAMP within Sertoli cells,
whereas ^-endorphin and/or another testicular opioid peptide
inhibit Sertoli cell proliferation. The intratesticular
administration of opiate antagonists inhibits testosterone
secretion, suggesting that ^-endorphin may stimulate testicular
testosterone secretion. Thus POMC and its derivatives may
represent a peptidergic system to be found in other steroid-
secreting tissues, namely placenta, testis and adrenal (Bardin,
1984).
1.2.5.2: Neuroregulation of ACTH secretion
Anterior pituitary corticotroph cells receive blood from the
hypothalamic-pituitary portal circulation. Secretion of POMC is
under the direct control of the hypothalamic neurosecretory hormone
known as CRF. This peptide is secreted into the portal circulation
by neurones whose somas are localised in the mediobasal hypo¬
thalamus, with axons projecting into the median eminence. CRF is
secreted in the vicinity of the portal capillaries in an episodic
manner. There are three major factors involved in the secretion of
ACTH:
i) Circadian rhythm. The existence of a circadian
periodicity of plasma corticosteroid levels is well-documented. In
the human peak levels of ACTH occur prior to or at the time of
awakening and decline during the day, reaching a nadir during the
late evening-early morning hours when episodic peaks of secretion
are scarce or absent. This circadian rhythm is independent of
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posture, persists with bed rest and persists in the absence of the
adrenals, indicating an endogenous periodicity, synchronised by
environmental phenomena such as the light-dark cycle (Krieger,
1978).
ii) Negative feedback. Corticosteroids exert negative feed¬
back upon ACTH secretion. Two components of this feedback have
been described: short delay, rate-sensitive, associated with the
rate of rise of the plasma corticosteroid concentrations and
possibly mediated by an effect on the release of CRF from the
hypothalamus, and delayed feedback, level-sensitive, associated
with the concentration of steroid reached in plasma, and probably
mediated by an influence of corticosteroids on the rate of
synthesis of CRF and/or the sensitivity of the corticotrophs to CRF
(Jones, 1978).
iii) Stress. Negative feedback of corticosteroids upon the
hypothalamus and pituitary can be overridden by severe stress such
as burns, surgery or hypoglycaemia to secrete ACTH, and markedly
elevated levels of both corticosteroids and ACTH are found in the
circulation at these times (Nelson, 1980).
Although CRF was the first hypothalamic hormone to be demon¬
strated, attempts to isolate it in pure state were unsuccessful.
One of the complicating factors has been the presence in posterior
pituitary and median eminence of vasopressin (VP). This neurohypo¬
physeal hormone per se has CRF-like activity. Recently, a 41-amino
acid polypeptide has been isolated from ovine hypothalamus (oCRF).
It is highly potent in stimulating secretion of ACTH by cultured
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anterior pituitary cells, and synthetic peptides with similar
structure display CRF activity in vitro and in vivo (Vale, 1981).
Immunoneutralisation in vivo by exogenous anti-CRF antiserum
inhibits the ACTH response to exogenous CRF and stress, and
markedly inhibits ACTH levels in adrenalectomised rats (Rivier,
1982). Moreover, the activity of the putative 41-residue CRF
in vitro is potentiated by arginine-VP (Turkelson, 1982). However,
the stimulation of CRF by stress seems to be independent of the
potentiating effect of VP, as antagonists of the neurohypophyseal
nonapeptide do not abolish ACTH response to psychological stress
(Mormede, 1983). It is thus likely that VP may be a biological co-
factor of CRF for certain types of response only.
The activity of the CRF-producing cells is modulated by the
nerve inputs from other areas of the brain (for review see Weiner,
1978). Noradrenergic nerves are possibly involved in a negative
control of CRF secretion (Lancranjan, 1979), whereas serotoninergic
neurones may stimulate the release of CRF (Fuller, 1981); a role
for histamine in the control of CRF is more controversial.
Aminobutyric acid (GABA) may have an inhibitory action on CRF
secretion, and this has been used in the treatment of patients with
Nelson's syndrome with drug agonists of GABA (Dornhorst, 1983).
Opiate peptides are also possible modulators of CRF secretion; the
opiate agonist peptide D-Ala^-MePhe^-Met-enkephalin-O-ol (DAMME)
inhibits the secretion of ACTH (Delitala, 1981), and naloxone
causes an elevation in serum Cortisol in normal human subjects,
suggesting that a tonic inhibition on ACTH is exerted by endogenous
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opiates (for review see Grossman, 1983).
1.2.5.3: Actions of ACTH, N-POMC and P-LPH on the adrenal gland
ACTH was known for many years before details of its precursor
were elucidated. It is accepted at present that ACTH is the
pituitary hormone responsible for the control of steroidogenesis by
the adrenal cortex. A great deal of information regarding its
structure, biological acitivity, structure-function relationships,
assays and mechanism of action has been published (for review, see
Rees, 1979). ACTH exerts many actions upon the adrenal cortex,
including an increase in blood flow, production of hypertrophy,
depletion of ascorbic acid, depletion of cholesterol esters and the
synthesis of corticosteroids. It also stimulates the uptake of
lipoprotein-bound cholesterol and induces a number of adrenal
enzymes.
The initial event in the action of ACTH is its binding to
specific receptor sites on the membrane of the adrenal cell. This
is followed by the activation of the enzyme adenylate cyclase and
the production of cAMP. Increased intracellular cAMP levels cause
an activation of protein kinase activity which in turn is believed
to result in phosphorylation of the enzyme cholesterol ester
hydrolase, converting it from an inactive to an active form
(Trzeciak, 1973; Beckett, 1977; Naghshineh, 1978). The active
cholesterol ester hydrolase catalyses the hydrolysis of stored
cholesterol esters in the lipid droplets and thereby increases the
amount of free cholesterol available to the mitochondria resulting
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in an increase in cholesterol binding to cytochrome P-450 side-
chain cleavage enzyme. In the adrenal cortex, as in other steroid
secreting tissues, the rate-limiting step in steroid hormone
biosynthesis is the conversion of cholesterol ■■pregnenelone by
cytochrome P-450 side-chain cleavage enzyme (for reviews see
Schulster, 1976; Simpson, 1979).
The binding of ACTH to its receptor also causes a rapid
increase in membrane phospholipids (Farese, 1980; Farese, 1983)
resulting in the synthesis of phosphatidyl inositol monophosphate
(PI), biphosphate (PI2) and triphosphates (PI3). Both PI2 and PI3
stimulate cytochrome P-450 side-chain cleavage enzyme in a similar
manner to ACTH (Farese, 1979) resulting in the formation of
pregnenelone (Farese, 1981). Other phospholipids may be released
by the binding of ACTH to its receptor. Activation of
phospholipase A2 results in the release of arachidonic acid from
the cell membrane (Schrey, 1979).
Calcium is probably a further messenger in ACTH-mediated
steroidogenesis. Not only is calcium involved in the adenyl
cyclase system and phospholipid metabolism, but it may act as a
messenger in its own right. It has been known for some time that
calcium can stimulate steroid hydroxylations in the adrenal
mitochondria (Peron, 1968) and in particular stimulates cytochrome
P-450 side-chain cleavage enzyme (Simpson, 1975). Furthermore,
calcium-induced stimulation of pregnenelone formation is caused by
a redistribution of cholesterol within the mitochondrial membranes,
increasing the proportion of cholesterol bound to P-450 side-chain
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cleavage enzyme. The mobilisation of calcium from extracellular to
intracellular stores may be controlled by the metabolites of the
phosphatidyl inositol pathway (Michell, 1975) and the intracellular
content of calcium is regulated by the intracellular actvity of
calmodulin (Hall, 1981).
Since the discovery of POMC there has naturally been a search
for a possible biological role for the N-terminal peptide. Indeed,
N-POMC derived from a mouse pituitary tumour cell line has been
shown to potentiate ACTH-induced steroidogenesis by isolated rat
adrenocortical cells (Pedersen, 1980a), but it was necessary to
trypsinise the peptide for it to be effective. However, trypsin
and its inibitors may directly influence adrenal steroidogenesis in
vitro (Raven, 1982; Raven, 1983; Pedersen, 1983), providing one
explanation for this intriguing observation. Alternatively, the
biological activity of N-POMC may reside in a smaller part of the
fragment that is released by trypsinisation. This may be in the
region ofJf-MSH. Synthetic /3-MSH is also capable of potentiating
ACTH-stimulated adrenocortical steroidogenesis and stimulating the
activity of the adrenocortical enzyme, cholesterol ester hydrolase
(Pedersen, 1980b). In contrast, it has been shown that Lys-^-MSH
failed to stimulate an increase in cAMP or membrane phospholipids
(Farese, 1983). Other authors have also described the presence of
ACTH-potentiating factors in peptides of high molecular weight
obtained from rat anterior pituitary extracts (Iida, 1981). Human
N-POMC significantly potentiates ACTH-stimulated steroidogenesis
in vitro using superfused trypsinised isolated rat adrenocortical
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cells (Al-Dujaili, 1981a). The mechanism of action of potentiation
appears to require the presence of intact transcriptional
mechanisms, since the effect of N-POMC is abolished by inhibitors
such as actinomycin D and mithramycin (Al-Dujaili, 1982).
A further role has been suggested for N-POMC-derived peptides
(Estivariz, 1982). Some fragments (N-P0MC-|_28) derived by limited
proteolysis from N-POMC are potent stimulators of adrenal DNA
synthesis in vitro, and of adrenal mitosis in vivo. Furthermore,
the administration in vivo of antisera directed against the extreme
N-terminal portion of N-POMC 1_28 an8 the mid-portion of N-POMC 1 .74
both prevented compensatory hyperplasia of the adrenal gland
remaining after unilateral adrenalectomy (Silas, 1983). Thus N-
POMC may be responsible, in part, for the regulation of adreno¬
cortical cell growth. The activation of cholesterol ester
hydrolase activity, originally observed by Pedersen (1980a) is also
mediated by another region, N-POMCgy.^.
Little is known about the adrenal action of J3-LPH/p-endorphin.
However, it has long been thought that a non-ACTH pituitary factor
may play a role in the regulation of aldosterone during sodium
depletion. Indeed, )3-LPH has been shown to stimulate aldosterone
secretion by isolated rat adrenal zona glomerulosa cells (Matsuoka,
1981). J3-MSH was equally potent as J3-LPH but concentrations of the
peptides were pharmacological rather than physiological. ^3-
Endorphin failed to stimulate aldosterone secretion, in contrast to
that reported previously (Shenker, 1979). Sodium depletion
enhances the sensitivity of adrenal zona glomerulosa cells to p~
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MSH (Yamakado, 1982) and aldosterone concentrations obtained by
maximal doses of J3-MSH were similar to those achieved by maximal
doses of angiotensin II. Thus J3-MSH and relate peptides may play a
role in the regulation of aldosterone secretion in the rat,
particularly in the salt-depleted state.
1.3: The Testis
1.3.1: Historical perspectives
The testis has long been recognised as the organ responsible
for fertility in men. Indeed, the word 'testify' has its origins
in the Roman practice of refusing a testimony to stand unless the
man could prove that his testicles were intact.
It was Hamen in 1677 who first discovered spermatozoa but it
was not until 1841 that these cells were found to originate from
the testis and 1865 that they were proved to be involved in
fertilisation. The structure of the testis was described in 1668,
the Leydig cell was named after its discoverer, von Leydig, in 1850
and the Sertoli cell was named for its discoverer ,j the German
scientist von Ebner, in 1888. In 1903 the Leydig cell was
postulated as the site of synthesis of many factors responsible for
the development of male characteristics. In the 1930s the
androgens androstenedione and testosterone were purified and the
separate pituitary products Luteinising Hormone (LH) and Follicle
Stimulating Hormone (FSH) identified. Inhibin was postulated as a
testicular product to regulate anterior pituitary FSH secretion in
1932 (source, Bartlett, 1985).
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1.3.2: Testicular structure and function
The mammalian testis is separated into two major compartments
- the avascular seminiferous tubules (82% of testicular mass) and
the vascularised interstitial space (16% of testicular mass) (Mori,
1980).
The seminiferous tubules are the site of sperm production and
histology of its epithelium reveals a highly organised cycle of
spermatogenesis (Leblond, 1952). A detailed discussion of
spermatogenesis is not within the scope of this thesis.
The interstitial spaces of the testis contain Leydig cells (3%
of testicular mass), macrophages, fibroblasts, lymphatics and
interstitial fluid (Christensen, 1975). In the rat the volume of
this fluid increases with age and following hCG injection,
reflecting changes in the permeability of testicular blood vessels
(Sharpe 1977; Setchell, 1981; Sharpe, 1983a; for review see Sharpe,
1984). The compartmentalisation of the testis into seminiferous
tubules and the interstitial spaces is not only anatomical but also
functional, isolating the seminiferous epithelium either by the
layer of myoid cells that surrounds the tubules (Dym, 1970) or by
the Sertoli cells, linked together by tight junctions (Setchell,
1980a). This functional barrier is thus able to maintain the
hormonal environment of the seminiferous tubules that is required
for normal spermatogenesis. It is thought that lipid soluble
materials enter the seminiferous tubules by traversing the Sertoli
cells (Setchell, 1980a), whereas water soluble materials are
prevented from entering by the spaces between the Sertoli cells
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because of the tight junctions. The Sertoli cells also secrete an
androgen-binding protein (ABP) in response to FSH (Fritz, 1975) and
androgens (Elkington, 1975). ABP has a high affinity for testo¬
sterone diffusing into the tubules from the interstitial spaces and
binding of the androgen may prevent its further metabolism,
maintaining a high concentration of androgen within the tubule
(Dorrington, 1980).
The presence of the Sertoli cell barrier has major impli¬
cations for the physiology of the testis. It is of great interest
that this barrier appears during pubertal development (approxi¬
mately 30-50 days of age) (Setchell, 1980b), and is associated with
the parallel development of a barrier in the testicular capillaries
that excludes certain dyes from access to the interstitial space.
The development of a barrier may, therefore, account for the
inability of the testis in vitro to convert exogenous progesterone
to androgen during puberty, whereas this in vitro conversion is
easily achieved before and after puberty (Steinberger, 1968).
The Leydig cell is the source of testosterone production by
the testis. In the rat, there are two generations of Leydig cells
with different morphological appearances. The first generation, or
fetal Leydig cells, appears in utero as early as the fifteenth day
of gestation and disappears after birth. The second generation, or
adult Leydig cells, appears in puberty in association with a
simultaneous reduction of fetal cells (Clegg, 1966; Lording, 1972;
Picon, 1980). The adult population is derived by differentiation
from precursor cells as well as directly from dividing differen-
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tiated cells (Hooker, 1970). The Increase in the population of
adult Leydig cells is accompanied by a progressive increase in
plasma testosterone concentrations (Lescoat, 1982). The majority
of the enzymes involved in the biosynthetic pathway of testosterone
reach their peak activity at 30-35 days of age (Inano, 1967; Payne,
1977). The exception is the enzyme 17J3-hydroxysteroid oxido-
reductase, the final enzyme in the pathway, which reaches its peak
activity slightly later. In association with the activity of these
enzymes there is a significant surge in plasma LH levels from day
30 to 35 and plasma testosterone concentrations (Lescoat, 1982; see
Sharpe, 1982 for review), suggesting that the development of the
adult population of Leydig cells is under the control of the
anterior pituitary. Indeed, the development of these cells can be
inhibited by hypophysectomy (Hooker, 1970). Whilst LH is the major
hormone to control Leydig cell function, elevated plasma FSH levels
during puberty also correlate with the development of Leydig cells
(Sharpe, 1982). Since Leydig cells do not possess FSH-receptors,
it is possible that the FSH-dependent Sertoli cell may influence
the development of adult Leydig cells.
1.3.3: Testicular steroidogenesis
The Leydig cell is the target tissue for the peptide hormone
LH which is secreted by the anterior pituitary. Leydig cells
synthesise and secrete testosterone involving biosynthesis from
acetate via cholesterol (Hall, 1969). The rate-limiting step in
testosterone biosynthesis, as in other steroid-secreting tissues,
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is the conversion of cholesterol » pregnenolone by side-chain
cleavage. The major biosynthetic pathways of steroid-secreting
tissues are illustrated in figure 1.1. However, the principle
steroids secreted by rat Leydig cells are progesterone, 17eC-
hydroxyprogesterone, androstenedione and testosterone (Chubb,
1979b). Thus in the rat testis there is little activity in the
pathways:
i) 21-hydroxylase: progesterone » 11-deoxycorticosterone
and 17 -hydoxyprogesterone » 11-deoxycortisol.
ii) 7,20-desmolase: 17<X-hydroxypregnenelone »
dehydroepiandrosterone » dehydroepiandrosterone sulphate.
The pathways for testicular steroidogenesis in the rat are
illustrated in figure 1.3. It will be seen that steroidogenesis
takes place in two compartments - the mitochondria and the cyto¬
plasmic endoplasmic reticulum. The pathway of steroidogenesis from
cholesterol to testosterone involves cytochrome P450-dependent
steroid hydroxylases. The conversion of cholesterol to
pregnenolone (side-chain cleavage) takes place in the mitochondria
but the subsequent metabolism of pregnenelone is carried out in the
endoplasmic reticulum:
i) 17-hydroxylase: pregnenelone » 1Ttf-hydroxypregnenelone
» (3^-hydroxysteroid dehydrogenase plus isomerase) 17o<-
hydroxyprogesterone.
ii) 3p-hydroxysteroid dehydrogenase plus isomerase:
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Unlike the adrenal, steroidogenesis remains in the
endoplasmic reticulum without returning to the mitochondria. This
factor may therefore be of some importance in adrenal » gonad
interactions, permitting the direct testicular utilisation of any
steroid precursors that are secreted by the adrenal gland into the
circulation.
From 17*X-hydroxyprogesterone, the final common path in
testosterone biosynthesis is » (17,20 desmolase) androstenedione
» (17 hydroxysteroid oxoreductase) testosterone.
1.3.4: Methodology for the study of testicular steroidogenesis
Like the adrenal gland, removal of testicular tissue and
manipulation under isolated conditions gives in vitro results
which, with due caution, can be related to in vivo conditions. The
rat testis has been subjected to a wide variety of procedures
involving either:
i) static incubations of isolated whole testis, isolated rat
Leydig tumour cells (Browning, 1983) and freshly purified isolated
cells (Mendelson, 1975a; Mendelson 1975b).
ii) superfusion of testes, isolated rat Leydig tumour cells
(Segaloff, 1981) and freshly isolated testicular cells (Davies T F,
1981; Kuhn-Velten, 1982).
iii) perfusion of the whole organ either in vitro (Chubb,
1979a) or in situ (Frederik, 1973; Baker, 1977).
Experiments with perfusion of the whole organ have the
disadvantages of limited tissue viability and the development of
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vascular disturbances, resulting in oedema and underperfusion
(Baker, 1980). Next to in vivo experimentation, continuous super-
fusion is, therefore, probably the most suitable for in vitro
studies.
In vitro cell suspensions of testicular tissue are prepared by
digestion of whole decapsulated testes with collagenase (Davies,
1979), without mechanical dispersion. Dispersed testicular cells
are usually incubated in Krebs-Ringer buffer with glucose and
albumen, either in static incubation or in a continuous superfusion
system. As with isolated adrenal cells, proponents of superfusion
technology point out that in static incubations products remain in
the medium and may alter secretion rates or be processed to
abnormal end-products. Superfusion overcomes these problems and
provides a system for the dynamic study of testicular steroido¬
genesis. Static incubations are limited to short time intervals
and isolated cells are better preserved in the superfusion system
for experiments of two hours or more. In the superfusion system, a
suspension of either isolated-mixed testicular (Davies T F, 1981)
or Leydig tumour cells (Segaloff, 1981) produces low basal levels
of steroid hormone that respond to both ovine-LH (oLH, over the
dose range 1-1000 ng/ml) or hCG (1 ng/ml). There are substantial
differences in the testosterone response by isolated cells to oLH
when compared with hCG. The response curve to a pulse of oLH is
Gaussian in its distribution and the duration of its effect is
confined to the period that oLH remains in the superfusate. In
contrast, the response to a pulse of hCG is skewed to the right,
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persisting after the superfusion of hCG through the system.
Repeated stimulation of the isolated cells with either oLH or 8-Br-
cAMP leads to diminished responsiveness. This presumably reflects
either a loss of cell viability or 'down-regulation' of LH
receptors that may occur in the target organ following repeated
trophic stimuli.
Following collagenase dispersion, functional and morphological
studies of isolated testicular cells have been performed. When
viewed under the phase contrast microscope they are characterised
by a yellowish appearance with a granular texture and surrounded by
a bright yellow halo (Gale, 1982). The active population of
collagenase-dispersed rat Leydig cells may be composed of two or
more subpopulations of cells with different densities and different
biological activities when purified by Ficoll (Janszen, 1976) and
metrizamide (Payne, 1980b). However, other studies on the
population of collagenase-dispersed cells, whilst demonstrating two
subpopulations of Leydig cells, have shown no difference in
morphology or biological activity when purified using metrizamide
with (Aquilano, 1984) or without centrifugal elutration (Payne,
1980a). It is therefore difficult to know whether to attribute
these findings to differences in methodology or to real differences
in Leydig cell population.
1.3.5: The hypothalamic-pituitary-testicular axis
1.3.5.1: Physiology of gonadotrophin secretion
The anterior pituitary secretion of gonadotrophins is at any
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time influenced by an interplay between gonadal steroids and the
hypothalamic secretion of gonadotrophin-releasing hormone (GnRH).
The influence of sex steroids is easily demonstrated by the
increased secretion of both gonadotrophins in response to
castration. However, the actions of both these hormones are
separated within the testis, LH acting upon the Leydig cell and FSH
upon the seminiferous epithelium (Greep, 1936; Dorrington, 1974).
Testosterone is the major signal in the peripheral circulation
capable of modulating the anterior pituitary secretion of LH in the
male rat (Kingsley, 1973; Drouin, 1976; Giguere, 1981), whereas the
major peripheral signal regulating the anterior pituitary secretion
of FSH is inhibin (Main, 1979; Baker 1983; Steinberger 1983).
1.3.5.2: Neuroregulation of gonadotrophin secretion
During the course of studies of LH secretion in castrated
primates, marked variations in the levels of LH were observed. On
making measurements at more frequent intervals the secretion of LH
was discovered to be pulsatile (Diershke, 1970) and this finding
was later extended to the experimental male rat (Gay, 1972; Kalra
1977; Ellis, 1982). Low levels of pulsatile secretion are
established early in the juvenile period and well established by
the onset of puberty (Andrews, 1981), but with advancing age there
is progressive loss of periodicity (Meites, 1982). Pulsatile
secretion of LH occurs at regular intervals of 50-70 minutes.















Figure 1.4: Circadian rhythm of serum levels of LH, progesterone,
dihydrotestostone and testosterone in the male rat (from Kalra,
1977).
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secretion with other cireadian rhythms, the circadian secretion of
progesterone appears to be related to a biphasic secretion of
testosterone by the testis (Fig 1.4, redrawn from Kalra, 1977).
The pulsatile release of LH is presumably based on an episodic
secretion of GnRH by the hypothalamus (pulse generator) (for review
see Kalra, 1983; Belchetz, 1983). The inescapable conclusion from
experiments by Knobil (1980) is that GnRH acts in a permissive
fashion to prime anterior pituitary gonadotrophs. Anterior
pituitary secretion of LH is subject to various factors including
the hypothalamic secretion of GnRH as well as the influences of
sex-steroids.
i) Pulse generator. GnRH activity is unevenly distributed
throughout the rat brain. Concentrations are highest in the median
eminence with lower levels in the organum vasculosum of lamina
terminalis (OVLT), arcuate nucleus (ARC), reterochiasmatic area
(RCA), suprachiasmatic nucleus (SCN) and supraoptic nucleus
(McCann, 1960; Harris, 1961; for review see Kalra, 1983). Studies
have been extended to localise GnRH activity to specific GnRH-
secreting neurones. These neurones converge from the brain into
the RCA, traversing to the premamillary zone and terminating in the
primary portal plexus of the anterior pituitary. The densest
accumulation of GnRH-secreting neurones is to be found in the
median eminence. The origin of these fibres has been traced by
deafferentiation experiments, lesion studies as well as pharma¬
cological studies to the SCN, mediobasal hypothalamus as well as
areas outside the hypothalamus. Thus the pulse generator appears
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to be a complex anatomical network of GnRH-secreting neurones that
innervate the median eminence and receive a variety of neurophysio-
logical and neuropharmacological signals from within and without
the hypothalamus. Dopamine, catecholamines, serotonin, acetyl¬
choline and opioid peptides are all important neurotransmitters
that modulate the pulse generator. However, the precise mechanisms
involved in the generation of episodic GnRH secretion are poorly
understood. According to one hypothesis, the clock-like precision
of GnRH secretion resides within the peptidergic neurones, with
modulation of the frequency and amplitude of secretion of GnRH by
other neural and hormonal inputs. Alternatively, periodic
discharge of GnRH may arise outside GnRH-secreting neurones in a
network of nerves that imposes its own periodicity on GnRH
secretion (for review see Kalra, 1983).
ii) Negative feedback. Testosterone is the major signal in
the peripheral circulation capable of modulating the anterior
pituitary secretion of LH in the male rat, acting both directly at
the level of anterior pituitary gonadotrophs (Kingsley, 1973;
Drouin, 1976; Giguere, 1981) and indirectly at the level of the
hypothalamus (Damassa, 1976; Clayton 1982; Kalra 1983). There is a
daily rhythm of the testicular secretion of testosterone upon
which wide fluctuations may be superimposed (Bartke, 1973; Kinson,
1973; Kalra, 1977; Mock, 1978; Kalra, 1979; Keating, 1979). Within
hours of castration, there is a rapid rise in plasma LH levels
associated with an increased frequency of LH secretion (Nansel,
1979; Kalra, 1983) and a later increase in the pulse amplitude.
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Androgen replacement returns the pattern of LH secretion to that of
Intact rats. Testosterone replacement appears to reduce pulse
amplitude rather than pulse frequency (Nansel, 1979) unless
androgen replacement is administered prior to castration, in which
case both pulse amplitude and frequency are reduced (Steiner,
1982). Androgens, therefore, modulate the response of anterior
pituitary gonadotrophs to the periodic signal generated by the
hypothalamus. This is supported by suppression of the LH-response
to GnRH by anterior pituitary cells in vitro following pretreatment
with testosterone (Drouin, 1976), and enhancement of this response
by anterior pituitary cells obtained from castrated rats (O'Connor,
1980). Androgens may also act in vitro by reducing the number of
GnRH receptors (Giguere, 1981).
The role of androgens in the regulation of the hypothalamic
secretion of GnRH is less clear. Whilst testosterone and its
metabolites increase and castration decreases the median eminence
content of GnRH, there is no evidence that these changes influence
the amount of GnRH secreted by the hypothalamus (Kalra, 1983).
In addition to testosterone, its metabolites - dihydrp-
testosterone and oestradiol - circulate in the blood in sufficient
concentrations to act in their own right or in concert with other
androgens on the hypothalamo-pituitary axis (Damassa, 1976; Kalra,
1977; Kalra, 1981). However, evidence that progesterone influences
the anterior pituitary secretion of LH is equivocal. The adminis¬
tration of progesterone to both intact and castrated male rats
either reduces or has little influence upon plasma LH concentrat-
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ions (Kingsley, 1973; Brown-Grant, 1974; Aiyer, 1976; Fink, 1976).
Inhibin is the major signal in the peripheral circulation
capable of modulating the anterior pituitary secretion of FSH,
acting directly on the pituitary (Baker, 1983) as well as at the
level of the hypothalamus to modulate the secretion of GnRH
(Labrie, 1978).
iii) Stress. The diverse effects of stress upon the anterior
pituitary, adrenal and gonadal secretion of hormones is well known
(for review see Andrews, 1977). In particular, stress in various
forms including animal handling, blood collection, novel environ¬
ments and anaesthesia may have profound and adverse effects on the
hypothalamo-pituitary-gonadal axis in rats.
In male rats, the acute response to stress provokes a marked
increase in plasma LH concentrations (Dunn, 1972; Krulich, 1974;
Euker, 1975; Turpen, 1976; Lorenzen, 1980; Lescoat, 1984) as well
as an associated rise in plasma testosterone concentrations
(Kniewald, 1971; Kamel, 1978; Lescoat, 1984). The initial rise in
gonadotrophin secretion observed during this acute phase is also
associated with increased secretion of ACTH and prolactin from the
anterior pituitary and increased secretion of corticosterone and
progesterone from the adrenal gland (Euker, 1975; Lorenzen, 1980;
Lescoat, 1984).
However, this acute response is short-lived, lasting
approximately 30-90 minutes, and is then followed by a chronic
phase, characterised by profound suppression of secretion of both
gonadotrophin (Lorenzen, 1980; Ringstrom, 1984) and testosterone
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(Free, 1973; Stahl, 1984). The duration of this chronic phase
usually lasts from 4 to 48 hours, or more and presumably reflects
adaptation of the hypothalamus (GnRH) or pituitary (LH) to stress.
GnRH is not only confined to the hypothalamus but is to be
found in a wide range of tissues including the adrenal glands,
pancreas, pineal, placenta, ovary and testis (Sharpe, 1984). GnRH
acts directly on the testis to modulate LH-induced steroidogenesis,
and the testicular secretion of GnRH by Sertoli cells may be an
important local regulator of testosterone production by the testis
(for review see Sharpe, 1984).
1.3.5.3: Actions of gonadotrophin on testicular steroidogenesis
LH was first purified from the anterior pituitary in the 1930s
and its availability provided evidence that LH directly stimulated
Leydig cells by maintaining normal Leydig cell morphology after
hypophysectomy (Greep, 1936). However, it was not until much later
that it was shown that the rat Leydig cell was controlled by the
anterior pituitary secretion of LH (Mancini, 1967). Both LH and
hCG stimulate testosterone production in freshly dispersed rat
Leydig cells (Mendelson, 1975a) and in Leydig cells in primary
culture (Hsueh, 1980). Increased steroidogenesis is mediated by
the binding of LH to specific receptors, activation of adenyl
cyclase and increased formation of cAMP (Catt, 1978). The
subsequent cAMP-mediated events result in an increase in
testicular steroidogenesis. The stimulation of testosterone
synthesis by the administration of hCG to freshly dispersed Leydig
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cells is dependent on both RNA and protein synthesis (Mendelson,
1975b), suggesting that the stimulation of steroidogenesis may be
mediated by increased synthesis of a protein that controls the
enzymes of the steroidogenic pathway. Cholesterol is mobilised
from lipid droplets in the cytoplasm by the enzyme cholesterol
ester hydrolase and it is subsequently converted in the
mitochondria by cytochrome P-450 (side-chain cleavage enzyme) to
pregnenelone. Administration of LH or hCG to hypophysectomised
rats restores the activity of the cytochrome P-450 side-chain
cleavage enzyme (Menon, 1967), 3p~hydroxysteroid dehydrogenase
activity (Samuels, 1956) and testosterone synthesis (Purvis, 1981).
GnRH also appears to directly influence testicular steroido¬
genesis. Agonists of GnRH bind specifically to purified rat Leydig
cells (Hunter, 1982), stimulating steroidogenesis in the short term
(Hunter, 1982; Sharpe, 1982) but inhibiting LH-mediated steroido¬
genesis in the longer term (Hunter, 1982; Massicotte, 1980).
However, GnRH agonists do not mediate their effect by using cAMP as
the intracellular messenger (Sullivan, 1984) but probably stimulate
the mobilisation of intracellular calcium stores (Sullivan, 1983a;
Sullivan, 1983b; Cooke, 1984). It has been recognised for some
time that calcium is required for steroidogenesis (Birmingham,
1953; Janszen, 1976), specifically by the enzyme responsible for
side chain cleavage (Hall, 1981). The metabolism of arachidonic
acids from membrane phospholipids by the enzyme phospholipase A^ is
also a calcium-dependent system. Calcium ionophores potentiate
arachidonic acid metabolism and stimulate LH-induced testicular
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steroidogenesis (Sullivan, 1984), whereas inhibitors of arachidonic
acid metabolism inhibit LH-induced testicular steroidogenesis (Dix,
1984). Other phospholipids have been implicated in steroidogenesis
(Farese, 1980) and the metabolism of phosphatidyl inositol may
control calcium entry into the cell (Michell, 1975). Thus GnRH may
act by stimulating the metabolism of membrane phospholipids
resulting in an influx of calcium, stimulating cholesterol
transport into mitochondria and the activity of its side-chain
cleavage enzyme (Cooke, 1984).
In contrast, FSH has little activity in testicular steroido¬
genesis. One of the major effects of FSH is to stimulate the
production of ABP by the Sertoli cells although the primary
regulator of this protein is probably testosterone (Tindall, 1976).
Both FSH and LH are necessary for the successful initiation of
spermatogenesis in immature and hypophysectomised animals (Lostroh,
1963; Steinberger, 1971; Go, 1971). However, FSH is not absolutely
essential for the maintenance of spermatogenesis once this has been
successfully established (Davies A G, 1981).
1.4: Adrenal » gonad interactions
The possibilities that the adrenal gland may influence the
gonad in both sexes has been the topic of intense speculation
(Kime, 1981). In the male rat the major pathways of influence
appear to be the direct influence of adrenal corticosteroids on the
testis and the indirect influence of these steroids on the anterior
pituitary secretion of gonadotrophins.
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1.4.1: Adrenal » gonad interactions in vivo: the effect of
adrenalectomy on gonadal function In the male rat
There have been several studies investigating the effects of
adrenalectomy on male gonadal function in vivo. These studies can
be divided into acute and chronic effects:
i) In acute studies (Kniewald, 1971) bilateral adrenalectomy,
performed in adult rats, results in a profound decline in plasma
testosterone levels when compared with those levels following
unilateral adrenalectomy, when the remaining adrenal gland
underwent compensatory hyperplasia (Fig 1.5). In contrast,
castration resulted in an initial rise in plasma testosterone
concentrations at one hour before declining to undetectable levels
at 64 hours. These results were interpreted as indicating that
either the adrenal gland is capable of secreting significant
amounts of testosterone or that the adrenal gland contributes to
the biosynthesis of testosterone by providing the testis with an
essential precursor; progesterone was tentatively proposed as such
a precursor. This is supported by the observation that the initial
rise in plasma testosterone concentrations following castration is
abolished when bilateral adrenalectomy is combined with castration.
Unfortunately, there are difficulties in the interpretation of this
study. It is not correct to compare plasma testosterone levels for
up to 12 hours following bilateral adrenalectomy with those levels
at 64 hours following unilateral adrenalectomy. Animals undergoing
unilateral adrenalectomy were presumably left for this longer
period to allow the remaining adrenal to compensate. This
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Figure 1.5: ^he acute effect of adrenalectomy on plasma testo¬
sterone levels in the male rat (Kniewald, 1971).
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study lacks sham-operated animals as appropriate controls, sampled
at time intervals comparable to their adrenalectomised
counterparts. It is not possible to determine from this study
whether the decline in plasma testosterone levels following surgery
is a result of adrenalectomy or the direct result of handling,
anaesthesia and surgical stress.
Adrenalectomy performed at the same time as castration delays
the post-castration rise in serum gonadotrophin concentrations for
up to 12 hours (Schwartz, 1977). These results were initially
interpreted as being consistent with a loss of adrenal steroids
capable of stimulating gonadotrophin secretion. However, in
subsequent experiments it was quite clearly demonstrated that
adrenalectomy performed either 12 hours before, or 12 hours after
castration also suppressed the rise in gonadotrophins as did sham
adrenalectomy (Lorenzen, 1980). Thus adrenalectomy-induced
inibition of gonadotrophin secretion cannot be directly mediated by
adrenal factors. The administration of the dopamine agonist drug
bromocriptine to adrenalectomised and castrated animals, and the
administration of ACTH to castrated animals, failed to influence
gonadotrophin secretion (Ringstrom, 1984). Thus the adrenalectomy-
induced inhibition of gonadotrophin secretion cannot be mediated by
prolactin or ACTH. These data are in keeping with a non-specific
effect of stress upon gonadotrophin secretion.
ii) In chronic studies it has been possible to demonstrate
an effect of adrenalectomy upon basal plasma testosterone concen
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trations and the acute testosterone response to stress.
a. Adrenalectomy reduces basal testosterone concentrations.
Lescoat et al (1982) were able to show that adrenalectomy performed
before the onset of puberty profoundly influenced the subsequent
maturation of the testis. Bilateral adrenalectomy or sham
operation was performed at 25 days of age prior to the estimation
of plasma LH and plasma testosterone levels during puberty (30-50
days). Adrenalectomy achieved a significant reduction both in
plasma testosterone as well as plasma LH concentrations when
compared with sham-operated controls (Fig 1.6). However, the
decline in plasma hormone levels in adrenalectomised animals was
also associated with reduced weight gain when compared with their
sham-operated counterparts. Since adrenalectomised animals did not
receive glucocorticoid replacement therapy, chronic glucocorticoid
insufficiency may have resulted in a general failure to thrive,
which in turn may have accounted for both the reduced weight gain
and non-specific suppression of plasma testosterone and gonado¬
trophs levels. However, by the end of the study the difference in
body weight between operated and sham-operated animals was no
longer significant.
Nevertheless, it had been previously demonstrated that
adrenalectomy performed in adult rats 14 days prior to sampling
abolished the normal circadian rhythm of testosterone secretion
(Kalra, 1977). Mean _+ SE 0800 and 2200 hours plasma testosterone
concentrations were respectively 4.67 _+ 1.14 ng/ml and 1.26 +_ 0.26









Figure 1.6: Plasma testosterone levels, plasma LH levels and body-
weight between 30-50 days of age in male rats adrenalectomised
(0 0) or sham-adrenalectomised (8 #) at 25 days of age
(Leseoat, 1982).
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1.49 _+ 0.3 ng/ml in adrenalectomised animals. The reduction in
plasma testosterone levels in adrenalectomised animals at this time
was not associated with a significant change in either plasma LH or
progesterone concentrations when compared with sham-operated
controls. These observations strongly suggest that the adrenal
gland plays an important role in the circadian regulation of
testicular secretion although the circadian variation of serum
progesterone does not solely appear to be mediated by the adrenals.
However, hypothalamic deafferation abolishes both serum
testosterone and progesterone rhythms. Thus, both the mediobasal
hypothalamus and the adrenal glands are responsible for the
circadian variation in testicular testosterone secretion. Similar
findings have been reported by other workers. Adrenalectomy
performed in adult rats 10 days before sampling significantly
reduced basal plasma testosterone concentrations as well as plasma
LH concentrations when compared with sham-operated controls
(Lescoat, 1984). However, in contrast to these findings, other
workers have been unable to demonstrate any chronic effect of
adrenalectomy on plasma testosterone or gonadotrophin levels
(McNeilly, 193o). Nevertheless, these data provide persuasive
evidence that an adrenal product is capable of stimulating the
testis.
b. Adrenalectomy reduces the acute testosterone response to
stress in the rat. In the acute phase of stress in male rats there
is a marked increase in the anterior pituitary secretion of ACTH,
prolactin and gonadotrophin, increased secretion of corticosterone
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and progesterone from the adrenal gland and Increased secretion of
testosterone from the testis. Since testosterone levels in the
blood fall to undetectable concentrations following castration, the
direct adrenal contribution to plasma testosterone concentrations
is negligible (Kniewald, 1971; Kalra, 1977). Yet, adrenalectomy
significantly reduces the rise in plasma testosterone
concentrations that occurs during the acute phase of stress,
suggesting that the acute testosterone response is mediated
indirectly by the adrenal (Lescoat, 1984).
1.4.2; Adrenal » gonad interactions in vivo; the effect of ACTH
and adrenal corticosteroids on gonadal function in the male rat
It has been well established that the administration of ACTH
to male rats inhibits testicular function (Baker, 1950; Asling,
1951; Saez, 1977; ), and that this inhibitory function requires the
presence of the adrenal gland to exert its effect (Mann, 1982).
Administration of ACTH to intact male rats increases serum
concentrations of corticosterone and progesterone and decreases
serum concentrations of LH, FSH and testosterone (Vreeburg, 1984).
Depression of testicular function by ACTH is presumably mediated by
the adrenal secretion of corticosteroids.
i) Glucocorticoids suppress the testicular secretion of
testosterone acting either directly upon the testis (Desjardins,
1971; Saez, 1977; Bambino, 1981; Welsh, 1982) or indirectly through
anterior pituitary gonadotrophs (Smith, 1971; Baldwin, 1974;
Baldwin, 1979). Administration of pharmacological doses of
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dexamethasone (600 pg daily for 3 days) to prepubertal rats
markedly inhibits hCG-stimulated testicular steroidogenesis and
appears to act by reducing the number of hCG-binding sites (Saez,
1977). These findings have been confirmed in adult rats employing
lower doses of dexamethasone (10-100 pg daily for 5 days) (Bambino,
1981). The administration of corticosterone in supraphysiological
doses to castrated animals increases the sensitivity of the
negative-feedback response to testosterone (Vreeburg, 1984). It
was also demonstrated that the administration of supraphysiological
doses of Cortisol (100 mg pellets by subcutaneous implantation)
over a 3-day period significantly suppresses plasma LH concen¬
trations in animals 12 hours post-castration, confirming that
glucocorticoids may exert an inhibitory effect over gonadotrophin
secretion. However, other studies have failed to demonstrate any
effect of ACTH or glucocorticoid in either intact or castrated rats
(Verjans, 1976). The reasons for these discrepancies are not
immediately clear.
ii) Progesterone levels fluctuate in the blood of male rats
with daily periodicity, and the rise in plasma progesterone
concentrations is casually related to a biphasic secretion of
testosterone. Progesterone administration to either intact or
adrenalectomised male rats is effective in raising both plasma
progesterone and testosterone levels without affecting plasma
gonadotrophins and its administration to hypophysectomised male
rats achieves similar results (Kalra, 1980). This confirms
previous observations that the administration of progesterone to
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intact or castrated male rats has little influence upon the
anterior pituitary secretion of gonadotrophins (Kingsley, 1973;
Brown-Grant, 1974; Aiyer 1976; Fink, 1976). Progesterone
stimulates testicular steroidogenesis (Kalra, 1980) and this is
presumably mediated by direct means rather than indirectly through
the stimulation of the anterior pituitary secretion of LH.
1.4.3: Adrenal » gonad interactions in vitro: the effect of the
adrenal secretion of corticosteroids on testicular steroidogenesis
in the rat
Other studies have provided in vitro evidence that the adrenal
gland is capable of influencing the testis. Using whole organs it
has been possible to demonstrate that the administration of ACTH to
fetal testes only increases testicular steroidogenesis when the
testes are incubated in the presence of fetal adrenal tissue and
not when the two tissues are separate (Warren, 1984b). This
strongly suggests that the fetal adrenal gland may play an
important role in the regulation of testosterone production by the
fetal testis. Furthermore, the fetal adrenal alone fails to
secrete significant amounts of testosterone in response to ACTH.
The novel technique of electrofusion has also been used to
demonstrate adrenal > gonad interactions (Podesta, 1984). This
technique produces a hybrid line of adrenal-Leydig cells that are
encompassed by one cell membrane. This hybrid cell secretes
corticosterone in response to the administration of LH and testo¬
sterone in response to ACTH, whereas isolated adrenal and Leydig
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cells alone fall to respond in this way. Moreover, these authors
were unable to demonstrate cooperation between adrenal and Leydlg
cells In the biosynthesis of testosterone when incubated in the
presence of ACTH in static incubations.
In vitro methods have also been used to demonstrate the
ability of isolated Leydig cells (Hall, 1969) and Sertoli cells
(Hall, 1969; Tcholakian, 1978) to metabolise progesterone to
testosterone. Intriguingly, the ability of the testis to utilise
progesterone is limited to certain periods of testicular maturation
(Steinberger, 1968). The addition of physiological concentrations
of progesterone to fetal testes stimulates testosterone production
(Habert, 1986). Testicular tissue derived from newborn rats
converts approximately 25-60% of progesterone to androgens but this
ability is lost (less than 1%) as the testes mature over the period
10-40 days of age, rising again to 40% in the post-pubertal animal
(Steinberger, 1968).
The mechanism of steroid entry into cells has recently come
under scrutiny (Ballard, 1979). It has been generally assumed that
glucocorticoids enter cells by passive diffusion by virtue of their
small molecular size and lipophilic nature. Certainly the
diffusion of naturally occurring glucocorticoids as well as
synthetic glucocorticoids is proportional to the extracellular
concentration of steroid (Samuels, 1970; Mayer, 1976; Plagemann,
1976). Other authors have argued for specialised transport systems
and propose that the cell membrane contains a component that binds
glucocorticoid and acts in a transport capacity (Brinkmann, 1972;
51
Milgrom, 1973; Harrison, 1974; Harrison, 1975; Harrison 1976; Rao,
1976; Harrison, 1977; Rao, 1977). Binding of glucocorticoid to the
cell membrane was achieved by two classes of receptor and inhibited
by prior exposure of the cell membrane to enzymes; uptake of
glucocorticoid into cells was under certain circumstances found to
be temperature-dependent. However, more recent studies have
disputed this concept and have demonstrated that velocity of
passage of a wide range of naturally occurring steroids through the
plasma membrane is extremely rapid (of the order of 10^ cm sec-^)
and occurs by simple diffusion (Giorgi, 1981). This applies to
free steroids and not to their conjugated counterparts.
Furthermore, the velocity of passage of steroid through the
membrane is closely related to the partition coefficient of that
steroid in n-octanol and water. Therefore it is likely that the
non-polar steroids such as progesterone will diffuse across
membranes with greater ease than polar steroids.
1.5: Conclusions
The notion that the adrenal gland may influence the testicular
secretion of testosterone in the rat Is persuasive and based upon
the following hypothesis:
i) Acute stress stimulates the hypothalamic-pituitary-adrenal
axis stimulating the adrenal secretion of corticosterone and
progesterone. The adrenal secretion of progesterone acts as a
direct positive signal whereas corticosterone acts as an indirect
negative signal to teststicular steroidogenesis.
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ii) Chronic stress exerts a non-specific inhibitory effect on
the hypothalamic-pituitary-testicular axis by suppressing the
anterior pituitary secretion of gonadotrophin.
The adrenal gland may therefore provide important external
signals to the internal rhythms of the hypothalamic-pituitary-
testicular axis. These signals may be of importance in their
effect upon the reproductive potential of the animal and may
contribute to the stress response of the male rat. The hormonal
response to mating is similar to that of acute stress resulting in
increased secretion of LH, prolactin and testosterone (Kamel,
1978). During the acute phase of stress the adrenal contribution
of progesterone stimulates the testicular secretion of
testosterone, whereas the adrenal secretion of corticosterone
suppresses the testicular secretion of this hormone. The
interaction of adrenal corticosteroids with the hypothalamo-
pituitary-testicular axis is therefore complex and the resultant
effect on testicular steroidogenesis may depend upon the balance of
these two signals. In the chronic phase of stress the overriding
response is suppression of the testicular secretion of testosterone
and this is presumably mediated through inihibition of GnRH and the
anterior pituitary secretion of LH.
The purpose of this thesis is to demonstrate that adrenal
corticosteroids influence the testicular secretion of testosterone





2.1: Animals and in vivo experimental techniques
All the animals used for these studies were male Wistar rats
bred from the colony at the Animal Unit, Western General Hospital,
Edinburgh. Rats were housed under conventional conditions at a
temperature of 19-21°C, with a light:dark cycle comprising 12 h
light and 12 h dark and fed ad libitum on rat chow (CRM(X) diet,
Labsure UK) and water. In order to prevent differences that may
relate to age, pubertal status and weight, rats were usually bred
specifically for each experiment, thus reducing any variation
between the groups. In the course of these studies the following
techniques were employed for in vivo experiments.
2.1.1: Anaesthesia
General anaesthesia was administered by an open method using a
mixture of Halothane (Fluothane, ICI UK) and 100% oxygen (British
Oxygen Company, UK) at a rate of 2 litres per minute via a
vaporiser (Fluotec Mk 3, Cyprane UK). Induction of anaesthesia was
usually achieved by placing the rat in a 'dessicator jar' with a
continuous flow of 4% halothane in oxygen. As soon as the rat was
unconscious, it was placed on the operating table with its tail
towards the operator and anaesthesia maintained through a face mask
(plastic filter funnel) employing 1-3% halothane in oxygen.
2.1.2: Adrenalectomy
Adrenalectomy (Waynford, 1980a) was performed by placing the
anaesthetised rat on its ventral surface with its tail towards the
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operator, the skin cleansed with a solution of 0.5% chlorhexidine
in alcohol 70% and the operation performed under aseptic
conditions. The hump on the back of the animal was identified and
a 2-3 cm midline incision was made with a scalpel. The connective
tissue was cleared away by blunt dissection using curved scissors
to expose the posterior abdominal wall. An incision was made by
means of curved scissors into the abdominal muscle on the left side
just posterior to the last rib and approximately one third down the
side of the animal on the left. Access was gained to the
peritoneal cavity which was gently explored using two pairs of
curved forceps and the left adrenal identified - it was usually
found close to the spine, between spleen and kidney. Once the
adrenal gland had been found the pedicle to the gland was grasped
with the forceps in the left hand and the right-hand pair was
inserted deeply to grasp the pedicle below the first pair. The
gland itself was not touched in case it ruptured and reimplanted
itself in the abdominal cavity. The adrenal gland was removed by
severing its pedicle by pulling the forceps away from each other.
The approach to the right adrenal is similar, with an incision one
quarter down the side of the animal on the right. The adrenal was
usually found between the kidney and the liver and the process of
removal of the right adrenal is similar to that of the left (Fig
2.1). No haemostasis was required and providing access to the
peritoneum was through a small incision no suture was necessary.
However, the midline skin incision was closed with two 11 mm skin
clips (Michel, Germany) using the appropriate clip applicator
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Figure 2.2: Technique of orchidectomy in the rat - see text for
details.
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(Roboz RS-9294, Germany). Postoperative oorticosteroid replacement
was not necessary providing the animals were given ad libitum
physiological saline {0.9% w/v) to drink. The success of total
bilateral adrenalectomy was subsequently confirmed by the finding
of undetectable plasma corticosterone concentrations and any animal
with detectable plasma cortcosterone levels was excluded from data
analysis.
2.1.3: Sham adrenalectomy
Sham adrenalectomy was performed under general anaesthesia by
gaining access to the peritoneal cavity on both sides, in order to
identify both left and right adrenal glands, without removal. The
peritoneal cavity and skin incisions were then closed as for
bilateral adrenalectomy.
2.1.4: Orchidectomy
Orchidectomy (Waynford, 1980b) was performed by placing the
anaesthetised animal on its back with its tail towards the
operator. The operation was performed under aseptic conditions and
the scrotum cleansed with a solution of 0.5% chlorhexidine in
alcohol 70$. A 1 cm median incision was made in the tip of the
scrotum with a pair of scissors and the connective tissue cleared
with blunt dissection to reveal the testes in their muscular sacs.
Pressure was often required to bring the testes down. A small
incision was then made at the tip of the muscular sac with a pair
of scissors sufficient to allow the passage of the cauda
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epididymis, caput epididymis, vas deferens and spermatic blood
vessels. A silk ligature (Mersilk, Ethicon, UK) was placed around
the vas deferens and spermatic blood vessels and divided distal to
the ligature permitting removal of the testis. The remaining piece
of vas was then pushed back into the sac and the incision closed
with a silk suture to prevent herniation. The other testis was
removed in the same way (Fig 2.2). The scrotal incision was then
closed with two 11 mm skin clips.
2.1.5: Administration of agents
i) ACTH: Groups of rats were injected either with 0.5 ml
sterile physiological sodium chloride (0.9$ w/v) (controls) or ACTH
1-24 (Tetracosactrin, CIBA-Geigy Laboratories, Switzerland) over
the dose range 0.01-10 ^ig in 0.5 ml sterile physiological sodium
chloride (0.9$ w/v) by intraperitoneal route.
ii) Progesterone: Groups of rats were injected either with
0.5 ml sterile physiological sodium chloride (0.9$ w/v) (controls)
or 100 pg progesterone (Sigma Chemical Company, USA) in 0.5 ml
sterile physiological saline (0.9$ w/v) by subcutaneous injection.
iii) Dexamethasone: Groups of rats were administered either
with 0.5 ml tap water (controls) or with dexamethasone (Merck
Sharpe and Dohme, UK) 100 pg in 0.5 ml tap water using an oral
intragastric blunt-ended dosing needle. Dexamethasone was
administered at 0900, 1700 and 2300 h on the day before the study
day and again at 0900 h on the day of the study.
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2.1.6: Blood sampling
Blood was collected from experimental animals by decapitation
into tubes containing lithium heparin (LH10, Brunswick, UK) and
then separated by centrifugation (MSE Coolspin, Fisons UK) at 2000
g for 15 minutes at 4°C and the plasma layer removed and stored
(approximately 2.5 ml) at -20°C until analysis for appropriate
steroid and LH concentrations. Great care was taken to avoid
stress in the experimental animals which were housed in a separate
room from that in which they were sacrificed. 'Companion' animals
were introduced at the time of experimentation in an attempt to
reduce stress that may result from isolation of the remaining rats
during sacrifice. Each experimental cage usually contained up to
eight experimental animals plus two 'companions'. Sacrifice was
performed in an adjacent room and the time from removing the animal
from its cage to decapitation was less than 20 seconds. Animals
were sacrificed on a rota basis, alternating with each experimental
group. All procedures were approved by the Home Office Animals
Inspectorate and licensed under the Cruelty to Animals Act 1876.
2.1.7: In vivo steroid hormone and LH assays
Steroid hormone analysis in plasma was performed by direct
(unextracted) and indirect (extracted) radioimmunoassay for
progesterone (Ratcliffe, 1982), testosterone (Corker, 1978),
corticosterone (Al-Dujaili, 1981b) and LH (Fraser, 1977), all
employing 125i_rac[ioligands • Plasma samples for estimation of
progesterone and LH concentrations were assayed neat, whereas
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plasma samples for estimation of testosterone concentrations were
assayed after dilution (1:5) following extraction, and samples for
corticosterone estimation were assayed after dilution (1:10).
2.1.7 • 1: Plasma progesterone assay
For direct assay, 50 pi of sample or standard (over the range
0.31 to 40 ng/ml in charcoal-stripped rat plasma) was added to 100
pi antibody (R31/7 raised in rabbits against 11i^-hemisuccinyl-
progesterone) in EDTA-phosphate assay-buffer (initial dilution
1:4,500; final dilution 1:25,000) and 400 pi of tracer ()^5i_
progesterone-11 jp-glucuronyl tyramine, 10,000 cpm) in assay-buffer,
containing danazol (400 ng in 400 pi or per tube) (1 TX-pregna-2,4-
dien-20-yon(2,3-d)isoxazol, Winthrop Laboratories, UK) and
incubated in borosilicate tubes (10 x 75 mm, Corning, USA) at room
temperature for 4 hours prior to the addition of second antibody.
Borosilicate tubes were used in preference to plastic because of
the nature of progesterone and its possible binding to plastic.
The purpose of the addition of the danazol was to displace
progesterone from binding to serum proteins, reducing that bound
from 35-40% to less than 4% with the amount of danazol used
(McGinley, 1979). Precipitation of tracer bound to antibody was
achieved with second antibody, consisting of 100 pi donkey anti-
rabbit antiserum (initial dilution 1:20; final dilution 1:150) and
100 pi normal rabbit serum (initial dilution 1:200; final dilution
1:1500), provided by the Scottish Antibody Production Unit
(Carluke, Scotland). Following addition of the second antibody,
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tubes were incubated overnight at 4°C and then centrifuged (MSE,
Coolspin, Fisons UK) at 2000 g for 30 minutes at 4°C, the super¬
natant decanted and the precipitate (bound) counted in a gamma-
counter (LKB-Wallac, UK). EDTA-phosphate assay-buffer (pH 7.4)
consisted of:
Na2HP0l| (8.52 g/1) (AnalaR, BDH, UK)
Na2EDTA (4.7 g/1) (AnalaR, BDH, UK)
BSA (0.25% w/v, fraction V, Miles, UK)
The final pH was adjusted to 7.4. The antibody was a gift
from Dr J E T Corrie, Department of Medicine, Western General
Hospital, Edinburgh and the tracer provided by the Department of
Clinical Biochemistry, Royal Infirmary, Glasgow.
Profiles for intra- and inter-assay precision are illustrated
in figure 2.3. Precision is calculated from five consecutive
standard curves as the coefficient of variation of the dose
estimate, derived from the standard deviation of dose estimate
divided by the dose (Ekins, 1983), and expressed as (CV%). Over
the working range 0.5 to 10 ng/ml intra- and inter-assay precision
are respectively 6% and 15% at 0.5 ng/ml and 10% and 7.5% at 10
ng/ml. The working range was usually determined by the limits 90-
10% B/B0 (see figure 2.4 for a typical standard curve) as well as
the precision profile.
Double dilution of rat plasma produced dilution curves
parallel to the standard curve (Fig 2.4) and cross-reactivities to
possible interfering steroids are in close agreement with those
previously published. There is no significant cross-reactivity
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with the synthetic glucocorticoid dexamethasone. This assay
compares favourably with other progesterone assays for rat plasma
(Kalra, 1977; Lorenzen, 1980).
2.1.7.2: Plasma testosterone assay
For indirect assay testosterone was first extracted from rat
plasma samples by incubating 100 pi of sample with 2 ml diethyl
ether (Anaesthetic ether, BP, May and Baker, UK), shaking at room
temperature for 5 minutes in a glass tube (Sterilin, UK). The
aqueous layer was frozen with solid carbon dioxide and the organic
layer decanted into borosilicate tubes (Corning Laboratories, USA)
and evaporated to dryness under a nitrogen stream at room
temperature. The extracted plasma was reconstituted in 0.5 ml
diethyl ether and evaporated again to dryness before reconstituting
with 500 jul (1:5 dilution) of 0.1 molar phosphate assay buffer (pH
7.4) with gelatin (0.1% w/v) and vortexed (Fisons, UK) for 20
seconds. 0.1 molar phosphate assay buffer (pH 7.4) consisted of:
NaCl (9 g/1)
Na2HP0ij.anhydrous (8.6 g/1)
NaH2P04. anhydrous (4.68 g/1)
All reagents were obtained from AnalaR, British Drug Houses,
UK. Gelatin (1 g/1) (G-2500 Sigma Chemicals, USA) was dissolved in
warmed buffer and the final pH adjusted to 7.4 with sodium hydr¬
oxide. Efficiency of extraction was assessed for each extraction
by incubating 10 pi of 3n-testosterone (Amersham, UK, to give










































































TBq/nmol) in 3 ml charcoal-stripped rat plasma for at least two
hours prior to extraction in parallel with samples for assay.
Average recovery was 93%.
For assay, 100 pi reconstituted (extracted) sample or standard
(over the dose range 0.025 ng/ml to 3.2 ng/ml in 0.1 molar
phosphate/gelatin buffer containing charcoal-stripped rat plasma
10% w/v) was incubated overnight at 4°C with 100 pi antibody (E01,
raised in the goat against testosterone-3-(-0-carboxymethyl)-oxime-
BSA, initial dilution 1:10,000; final dilution 1:30,000) and 100 pi
tracer (testosterone-3-(-0-carboxymethyl)-oxime-''25i-histamine,
3000 counts per minute), both in 0.1 molar phosphate-gelatin
buffer. Assays were incubated in plastic LP3 (Luckhams Ltd, UK)
tubes overnight at 4°C prior to separation by the addition of 1 ml
0.5% (w/v) dextran-coated charcoal in 0.1 molar phosphate buffer
and centrifuged (MSE Coolspin, Fisons, UK) at 2000 g for 15 minutes
at 4°C. The supernatant was aspirated, discarded and the remaining
pellet, unbound tracer (free) counted in a gamma counter (LKB-
Wallac, UK). The values were corrected for percentage recovery and
dilution. The antibody is a gift from the M R C Reproductive
Biology Unit, Chalmers Street, Edinburgh and tracer was prepared by
coupling testosterone-3-(-0-carboxymethyl)-oxime to ^5x_histamine
as described under in vitro methods (see section 2.2.5.6).
Profiles of intra- and inter-assay precision (CV%) are illus¬
trated in figure 2.5. Over the working range 0.1 to 1.6 ng/ml the
intra- and inter-assay precisions are respectively 6.8% and 10.9%
at 0.1 ng/ml and 5.5% and 13.0% at 1.6 ng/ml. The working range
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was usually determined by the limits 90-10? B/B0 (see figure 2.6
for a typical standard curve) as well as the precision profile.
Extracted samples when diluted, demonstrated parallelism to the
standard curve (Fig 2.6) and cross-reactivities to possible
interfering steroids are similar to those previously reported
(Bartlett, 1985). There is no significant cross-reactivity with
the glucocorticoid dexamethasone. This assay compares favourably
with other testosterone assays for rat plasma (Lescoat, 1982;
Wheeler, 1983; Stahl, 1984; Bartlett, 1985).
2.1.7.3: Plasma corticosterone assay
For direct assay 50 pi sample (diluted in Krebs-Ringer buffer
(1:10) containing BSA 0.2? (w/v) (fraction V, Miles Reagents, UK)
or standard (over the range 0.5 to 64 ng/ml in Krebs-Ringer buffer
containing BSA 0.2? (w/v) and charcoal-stripped rat plasma 10?
(v/v)) was added to 200 pi of antibody (R1/B3 raised in rabbits
against corticosterone-3-(-0-carboxymethyl)-oxime-BSA) (initial
dilution 1:20,000; final dilution 1:45,000) and 200 pi tracer
(corticosterone-3-(-0-carboxymethyl)-oxime-(^^5)-histamine, 3000
counts per minute, both assayed in phosphate/citrate bufffer pH 3.0
to displace corticosterone from its binding protein (Al-Dujaili,
1981b). Assay buffer (pH3.0) consisted of:
Na2HP04 (14.2 g/1)
Citric acid monohydrate (21 g/1)
BSA (0.1? w/v) (fraction V, Miles Reagents, UK).
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addition of 1 ml dextran-coated charcoal and centrifuged (MSE
Coolspin, Fisons UK) at 2000 g at 4°C for 15 minutes. The super¬
natant was aspirated, discarded and the remaining pellet, unbound
(free) tracer, is counted in a gamma counter (LKB-Wallac). The
antibody is a gift from Dr B C Williams, Department of Medicine,
Western General Hospital, Edinburgh and tracer was prepared by
coupling corticosterone-3-(-0-carboxylmethyl)-oxime to 125j_
histamine as described under in vitro methods (see section
2.2.5.6).
Profiles for intra- and inter-assay precision are illustrated
in figure 2.7. Over the working range 0.5 to 16 ng/ml the intra-
and inter-assay precisions are respectively 8? and 11.1% at 0.5
ng/ml and 6? and 7.5? at 16 ng/ml. The working range was usually
determined by the limits 90-10? B/BQ (see figure 2.8 for a typical
standard curve) as well as the precision profile.
Double dilution of rat plasma produced dilutional curves
parallel to the standard curve (Fig 2.8) and cross-reactivities to
possible interfering steroids are in close agreement with those
previously published. There is no significant cross-reactivity
with the synthetic glucocorticoid dexamethasone. This compares
favourably with other corticosterone assays for rat plasma
(Lescoat, 1984).
2.1.7.4: Plasma LH assay
Plasma levels of LH were measured by direct radioimmunoassay
as described by Fraser and Sandow (1977) and I am grateful to Dr R
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Sharpe, M R C Reproductive Biology Unit, Chalmers Street, Edinburgh
for supplying the reagents.
2.1.7.5: Preparation of chareoal-stripped rat plasma
For preparation of standards containing known quantities of
appropriate hormones for radioimmunoassay, it is necessary to
remove all endogenous steroids by charcoal-stripping. Activated
charcoal (Sigma Chemicals, USA) was washed three times with 0.1
molar phosphate buffer (pH 7.4 containing BSA (0.15? w/v)) in a
ratio of 0.3 g charcoal to 10 ml buffer. The charcoal/buffer
slurry was centrifuged (MSE Coolspin, Fisons, UK) between washes at
300 g at 4°C and the supernatant containing fine charcoal discarded
on each occasion. Rat plasma was clock-stirred overnight with the
washed charcoal in a ratio of 1 g (dry weight) charcoal to 10 ml
rat plasma. The plasma/charcoal slurry was then centrifuged at
2000 g for 1 hour and the supernatant decanted as charcoal-stripped
rat plasma. The efficiency of stripping was assessed by incubating
3 ml of the original rat plasma with 50 jul 3H-corticosterone for 2
hours at room temperature. The 'spiked' sample was treated in
parallel in the same way as the plasma intended for use as
standards. On average, 95? of 3H-corticosterone was removed by
this process. Plasma samples were then prepared as standards by
the addition of appropriate concentrations of appropriate hormone,
aliquoted and stored at -20°C until use.
2.1.8: Statistics:
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Statistical differences between groups were analysed by
Wilcoxon test for paired and unpaired data as appropriate, using a
BBC microcomputer (software, Dr C S Hetherington, Department of
Clinical Chemistry, University of Newcastle-upon-Tyne).
2.2: Materials and methods of in vitro techniques
Lowry and McMartin first described a superfusion system to
investigate steroidogenesis by isolated rat adrenal cells in vitro
in 1974. Cells were obtained by enzymatic digestion and suspended
on a polyacrylamide matrix using a 2 ml syringe as a superfusion
chamber. One or two superfusion chambers were used for each
experiment. This system has been adapted to a multicolumn isolated
cell superfusion system and used to investigate the interaction
between isolated rat adrenal and testicular cells in the secretion
of sex steroids. This system has the advantage of comparing
steroidogenesis from 10 parallel columns within each experiment.
2.2.1: Preparation of isolated whole adrenal cells
Ten adult male Wistar rats (250 g) were killed by carbon
dioxide narcosis and whole adrenals identified and removed. The
adrenal glands were cleaned of adhering fat using fine forceps and
a pair of fine scissors, then minced and digested. Digest took
place in a 100 ml pot (Sterilin, UK) containing a 10 ml solution of
collagenase (Worthington Diagnostic Systems, Flow Laboratories, UK)
at a concentration of 2 mg/ml in Krebs-Ringer buffer containing
bovine serum albumen (1% w/v) (BSA, fraction V, reagent grade,
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Figure 2.9: Photograph of the superfusion system.
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Miles Laboratories, UK) and glucose (0.2$ w/v) (AnalaR, BDH, UK)
for 60 minutes in a shaking water bath (Grant Instruments, UK) at
37°C and 120 cycles per minute (Tait, 1972). Cells were
mechanically dispersed with a 5 ml pipette at 30 and 60 minutes and
isolated cells separated from debris by filtration through a 100 ju
nylon gauze (Henry Simon Ltd, UK). Isolated adrenal cells were
then centrifuged at 300 g for 15 minutes at 10°C (MSE Coolspin,
Fisons, UK). The supernatant was discarded and the cell pellet
resuspended in Krebs-Ringer buffer and the cells counted and
adjusted to 1 x 10^ cells suspended in 0.5 ml so that 1x10^ could
be added to each superfusion chamber according to the experimental
protocol. This preparation is therefore unpurified containing
adrenocortical cells of the zona glomerulosa, fasciculata and
reticularis as well as from the adrenal medulla.
2.2.2: Preparation of isolated testicular cells
Ten male Wistar rats (250 g) were killed by carbon dioxide
narcosis and whole testes removed with the minimum of trauma.
Testicular cells were prepared by stripping the capsule from each
whole testis with the absolute minimum of mechanical force and the
testis then digested with collagenase. Each pair of testes were
incubated in a 50 ml pot (Falcon tissue culture flask, Becton
Dickinson Labware, USA) containing an 8 ml solution of collagenase
(Type I, Sigma Chemicals, UK) at a concentration of 0.25 mg/ml in
Krebs-Ringer buffer containing bovine serum albumen (1$ w/v) (BSA,



















































w/v) (AnalaR, British Drug Houses, UK) for 10 minutes in a shaking
water bath at 37°C and 60 cycles per minute. The subsequent digest
from the 10 testes was suspended in 100 ml Krebs-Ringer buffer in a
100 ml glass cylinder and allowed to sediment for 2 minutes by
gravity. The supernatant containing isolated testicular cells was
centrifuged (MSE Coolspin, Fisons UK) at 300 g for 15 minutes
(Davies, 1979). The cell pellet was resuspended in buffer and 10 x
10& testicular cells packed into each superfusion chamber according
to the experimental protocol. The preparation therefore represents
a 'crude' preparation of cells that corresponds to approximately
106 Leydig cells as estimated by 3J3-hydroxysteroid dehydrogenase
activity (Browning, 1983; Sharpe, 1983b).
2.2.3: The superfusion system
The superfusion system employed a multichannel peristaltic
pump (Desaga PLG, Uniscience, UK), an incubator (Gallenkamp, UK)
and a fraction collector (2070 Ultrorac II, LKB, UK) (Figs 2.9 and
2.10). Each superfusion chamber contained 0.5 g of polyacrylamide
gel (Bio-Gel, P-2, 200-400 mesh weight, Bio-Rad Laboratories, USA)
based upon a 20 p nylon mesh (Henry Simon Ltd, UK). Initial
experiments used 2 ml disposable plastic syringes (Gillette Sabre,
UK) as superfusion chambers. These syringes have the advantage of
having a hollow plunger so that when a 21 FG needle (Microlance,
Becton Dickinson, UK) is inserted into the bung and the 'female
piece' of the needle is removed, a through route is created for
superfusion. The syringes were assembled upside down and the 20 p
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nylon gauze is wrapped around the rubber bung to act as support for
the Bio-Gel and cells (Fig 2.10). Bio-Gel was weighed dry and pre-
wetted to form a slurry with 2.5 ml Krebs-Ringer buffer prior to
loading into the syringe by suction and the gel allowed to settle
while buffer was superfused through the chambers. Once the support
of gel upon nylon gauze was established, isolated cells were loaded
into the chamber by suction and the columns allowed to settle under
superfusion for one hour prior to experimentation. Buffer was
stored in the incubator during superfusion to maintain a constant
temperature of 37°C and the medium constantly gassed with a mixture
of 95? O2 : 5? CC>2' However, later experiments used superfusion
chambers manufactured from polytetrafluoroethylene (PTFE, Nylonic
Engineering Co Ltd, Cumbernauld, Scotland) (McDougall, 1978)
because non-polar steroids such as progesterone significantly
adhere to the plastic syringes and silcone tubing.
Using ^H-progesterone (Amersham pic, UK), only 5.3? of tracer
was recovered from labelled Krebs-Ringer buffer that was superfused
through a system of silicone tubing and Lowry columns, compared
with 53? for silicone tubing and PFTE columns and over 80? (mean of
10 columns) for PFTE connecting tubing (silicone tubing is still
retained for the pump) and PFTE columns. Using PFTE columns, PFTE
connecting tubing and retaining silicone pump tubing, the mean +_ SD
(?) recovery of steroids (all at a concentration of 5 ng/ml) from
the whole system was 86.3 +_ 5.3 for progesterone, 89.1 +_ 18.8 for
17(X-hydroxyprogesterone, 78.3 _+ 23.4 for androstenedione, 76.9 +_
13.9 for testosterone and 80.3 + 22.9 for corticosterone (mean of
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10 columns). Superfusion chambers were made from solid PFTE rods
(0.5 and 1.0 inches in diameter) by Mr Louis Mackie, Chief
Technician, Medical Physics Department, Radiotherapy Unit, Western
General Hospital, Edinburgh. The pump tubing was made from
silicone (Silicone C, internal diameter 1.0 mm and wall thickness
1.0 mm, Desaga PLG, Uniscience, UK) to deliver superfusion medium
at a rate of 0.5 ml/min, with connecting tubing manufactured from
PTFE (0.74 mm internal diameter, 0.254 mm wall and 0.051 mm
tolerance, Jencons, UK) and stream dividers were used as necessary
(Acculab, UK). Superfusion medium consisted of Krebs-Ringer buffer
containing BSA (0.2% w/v) and glucose (0.2% w/v) at a temperature
of 37°C maintained by the incubator and oxygenated with a mixture
of oxygen 95$ : 5$ carbon dioxide (British Oxygen Company, UK) with
or without stimuli. Isolated cells were stimulated by appropriate
stimuli in Krebs-Ringer buffer for a period of 10 minutes followed
by buffer alone for a period of 50 minutes (stimulus, control or
buffer are introduced by means of a two-way tap) and superfusate
samples collected every 5 minutes by the multichannel fraction
collector for steroid hormone analysis. Samples were stored at
-20°C prior to analysis by radioimmunoassay. Superfusion medium,
Krebs-Ringer buffer containing glucose (0.2% w/v) and BSA (0.2%
w/v), were made up on the morning of experimentation from the
following stock solutions:
NaCl 326 ml 0.77 molar solution (45 g/1)
KC1 7 ml 0.77 molar solution (57.5 g/1)
CaCl2 9.6 ml 0.55 molar solution (80.9 g CaCl2.2H20/l)
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KH2PO4 3.2 ml 0.77 molar solution (105.5 g/1)
MgS04 3.2 ml 0.77 molar solution (189.8 g MgS04.7H2O/I)
NaHCOg 336 ml 0.154 molar solution (12.9 g/1)
The volume was then made up to 2080 ml with distilled water,
glucose and albumen added and the medium gassed with 95? O2 : 5?
CO2 (BOC, UK) for 1 hour.
2.2.4: Stimuli for superfusion
i) ACTH: 1, 10, and 100 pg/ml of synthetic ACTH
(Tetracosactrin, CIBA-Geigy Laboratories, Switzerland) in super-
fusion medium were prepared immediately prior to use and superfused
over a 10 minute period according to the protocol.
ii) hCG: 50 ng/ml of human chorionic gonadotrophin (Pregnyl,
Organon Laboratories Ltd, UK) in superfusion medium was also
prepared immediately prior to use and superfused over a 10 minute
period according to the protocol.
iii) Progesterone: 10 ng/ml of progesterone (Sigma Chemical
Company, USA) in superfusion medium was also prepared immediately
prior to use and superfused over a 10 minute period according to
the protocol. Progesterone being a non-polar steroid was initially
dissolved in absolute alcohol in the preparation of stock solutions
and is subsequently serially diluted in alcohol until a concen¬
tration is achieved that is soluble in aqueous solution. The
alcohol was then evaporated in a sample concentrator and the sample
reconstituted in superfusion buffer and diluted to the
concentrations employed in the experiments. At these
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concentrations progesterone was readily maintained in aqueous
solution. This procedure was necessary in order to prevent
potential contamination of isolated cells with alcohol and
subsequent cell damage.
2.2.5: Steroid hormone analysis for in vitro fluids
Steroid hormone analysis in buffer were performed by direct
radioimmunoassay (either neat or in dilution) for progesterone
(Ratcliffe, 1982), 17iX.-hydroxyprogesterone (Wallace, 1984), andro-
stenedione, testosterone (Corker, 1978) and eorticosterone (Al-
Dujaili, 1981b), all employing 125i_radioligands. All the assays
wre adapted from existing plasma assays to be performed in
superfusion buffer.
2.2.5.1: In vitro progesterone assay
For direct assay, 200 pi of sample (either neat or in dilution
1:5 in superfusion medium) or standard (over the range 0.156 to 40
ng/ml in superfusion medium) was added to 100 pi of antibody (R31/7
as for the in vivo progesterone assay, initial dilution 1:6000;
final dilution 1:30,000) and 200 pi of tracer (^85j_pr0gesterone as
for the in vivo progesterone assay, 10,000 counts per minute), all
in EDTA-phosphate assay-buffer (pH 7.4). Samples were incubated in
borosilicate tubes 10 x 75 mm (Corning, USA) at room temperature
for 4 hours prior to addition of second antibody. Precipitation of
tracer bound to antibody was achieved with second antibody,
consisting of 50 ul donkey anti-rabbit antiserum (initial dilution
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1:10; final dilution 1:120) and 50 pi normal rabbit serum (initial
dilution 1:100; final dilution 1:1200), provided by the Scottish
Antibody Production Unit (Carluke, Scotland). Following addition
of second antibody, samples were incubated overnight at 4°C and
then centrifuged (MSE, Coolspin, Fisons, UK) at 2000 g for 30
minutes at 4°C, the supernatant decanted and the precipitate
counted in a gamma counter (LKB-Wallac, UK).
Profiles of intra- and inter-assay precision are illustrated
in figure 2.11. Over the working range 0.156 to 5 ng/ml intra- and
inter-assay precisions are respectively 8.6? and 12.5? at 0.156
ng/ml and 4.5? and 27? at 5 ng/ml. The working range was usually
determined by the limits 90-10? B/B0 (see figure 2.12 for a typical
standard curve) as well as the precision profile.
Double dilution of samples in superfusion buffer produced
dilutional curves parallel to the standard curve (Fig 2.12) and
cross-reactivities (Fig 2.13) to possible interfering steroids are
in close agreement with those previously published with significant
cross-reactivity to 11/-hydroxyprogesterone (15?) and 11-
deoxycortisol (3.0?).
Recovery of progesterone (observed) from superfusion medium is
in close agreement with that expected (Fig 2.14).
2.2.5.2: In vitro 17iX-hydroxyprogesterone assay
For assay, 100 pi of sample (either neat or diluted 1:5 in
superfusion medium) or standard (over the range 0.05 to 3.0 ng/ml
in superfusion medium) was added to 200 pi of antibody (raised in
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rabbits against 17o(-hydroxyprogesterone-3-(-O-carboxymethyl)-oxime-
BSA and microencapsulated, initial dilution 1:40; final dilution
1 :200) and 200 pi of tracer (17<x.-hydroxyprogesterone-3-(-0-
carboxymethyl)-oxime-^25j_histamine) both in 0.5 molar phosphate
assay-buffer (pH 7.4) and incubated in plastic LP4 tubes (Luckham
Ltd, UK) at room temperature for 45 minutes. Separation of tracer
bound to antibody was achieved by washing twice with 2 ml saline
(0.9$ w/v) containing polyoxyethylene(20)sorbitan monolaurate
(Sigma Chemicals, USA) (0.5$ v/v) as a detergent. After each wash,
tubes were centrifuged at 1500 g for 15 minutes and the supernatant
discarded. The remaining pellet, bound tracer, was counted in a
gamma counter (LKB-Wallac, UK). The microencapasulated 17-
hydroxyprogesterone antibody was a gift from Dr A M Wallace,
Department of Clinical Chemistry, Royal Infirmary, Glasgow and
tracer was prepared by coupling 17i';-hydroxyprogesterone-3-(-0-
carboxymethyl)oxime to ^25j_histamine (see section 2.2.5.6). 0.5
molar phosphate assay-buffer (pH 7.4) consisted of:
Na2HP0i|.anhydrous (7.1 g/1)
KH2P0i| (6.9 g/1)
Both reagents were available from AnalaR, BDH, UK and were
dissolved separately, each in 1 litre distilled water. 100 to 200
ml of KH2PO4 was then added to the solution of Na2HP04 until the pH
adjusted to 7.4. Following this, BSA (0.1$ w/v) (fraction V, Miles
Reagents, UK) was dissolved into solution and stored for use at
4°C.
Profiles of intra- and inter-assay precision are illustrated
89




























ANDROSTENEDIONE DMA CORTICOSTERONE PROGESTERONE CORTISOL PREGNENOLONEVOHPREGNENOLONE
11DEOXYCORTICOSTERONE11DEOXYCORTISOL ALDOSTERONE



















































in figure 2.15. Over the working range 0.25 to 4 ng/ml the intra-
and inter-assay precisions are respectively 10$ and 13$ at 0.25
ng/ml and 2.5$ and 10$ at 4 ng/ml. The working range was usually
determined by the limits 90-10$ B/B0 (see figure 2.16 for a typical
standard curve) as well as the precision profile.
Double dilution of samples in superfusion buffer produced
dilution curves parallel to the standard curve (Fig 2.16) and
cross-reactivities to possible interfering steroids (Fig 2.17) are
in close agreement with those previously published with significant
cross-reactivity to 17-hydroxypregnenelone (1.5$).
Recovery of 17^-hydroxyprogesterone (observed) from
superfusion medium is close to that expected (Fig 2.18).
2.2.5.3: In vitro androstenedione assay
For assay, 100 pi of sample (either neat or diluted 1:5 in
superfusion medium) or standard (over the range 0.031 to 2 ng/ml in
superfusion medium) was added to 100 jul of antibody (Guildhay,
HP/S/ 673-IA, raised in sheep against androstenedione-7 -
carboethylthioether-ovalbumen, initial dilution 1:90,000; final
dilution 1:270,000) and 100 pi of tracer (androstenedione-3-(-0-
carboxymethyl)-oxime-(^5x)-iodohistamine, 10,000 counts per
minute), all in 0.5 molar phosphate assay-buffer (pH 7.4). Samples
were incubated in plastic LP3 tubes (Luckhams Ltd, UK) at 4°C
overnight prior to separation with the addition of 1 ml dextran-
coated charcoal. Samples were immediately centrifuged (MSE
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supernatant was aspirated, discarded and the remaining pellet,
unbound (free) tracer, counted in a gamma counter (LKB-Wallac, UK).
The antibody was supplied by Guildhay Antisera, University of
Surrey and the tracer was prepared by coupling androstenedione-3-(-
0-carboxymethyl)-oxime with ^25j_histamine (see section 2.2.5.6).
Profiles for intra- and inter-assay precision are illustrated
in figure 2.19. Over the working range of 0.25 to 2 ng/ml the
intra- and inter-assay precisions are respectively 6.4% and 17% at
0.25 ng/ml and 10% and 11.5% at 2 ng/ml. The working range was
usually determined by the limits 90-10% B/B0 (see figure 2.20 for a
typical standard curve) as well as the precision profile.
Double dilution of samples in superfusion buffer produced
dilution curves parallel to the standard curve (Fig 2.20) and
cross-reactivities to possible interfering steroids (Fig 2.21) are
in close agreement with those previously published with significant
cross-reactivity to dehydroepiandrosterone (12.5 %), testosterone
(0.6%) and 11-deoxycortisol (0.2%).
Recovery of androstenedione (observed) from superfusion medium
is close to that expected (Fig 2.22).
2.2.5.4: In vitro testosterone assay
For assay, 100 pi sample (either neat or diluted 1:5 in super-
fusion medium) or standard (over the range 0.025 to 3.2 ng/ml in
superfusion medium) was added to 100 pi antibody (E01, as for
in vitro assay, initial dilution 1:10,000; final dilution 1:30,000)
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Figure 2.24: A typical standard curve for testosterone samples
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iodohistamine, 3000 counts per minute), both in 0.5 molar phosphate
assay-buffer. Assays were incubated in plastic LP3 tubes (Luckhams
Ltd, UK) overnight at 4°C prior to separation with 1 ml of dextran-
coated charcoal and centrifuged at 2000 g (MSE Coolspin, Fisons,
UK) at 4°C. The supernatant was aspirated and the remaining
pellet, unbound tracer (free), counted in a gamma counter (LKB-
Wallac, UK).
Profiles of intra- and inter-assay precision are illustrated
in figure 2.23. Over the working range 0.025 to 3.2 ng/ml intra-
and inter-assay precisions are respectively 8$ and 8.5$ at 0.025
ng/ml and 7.5$ and 15.5$ at 3.2 ng/ml. The working range was
usually determined by the limits 90-10$ B/BQ (see figure 2.24 for a
typical standard curve) as well as the precision profile.
Double dilution of samples in superfusion buffer produced
dilutional curves parallel to the standard curve (Fig 2.24).
Cross-reactivities (Fig 2.25) with possible interfering steroids
are in close agreement with those previously published with
significant cross-reactivities to dihydrotestosterone (10$) and
androstenedione (0.08$).
Recovery of testosterone (observed) from superfusion medium is
close to that expected (Fig 2.26).
2.2.5.5: In vitro corticosterone assay
For assay, 100 pi sample (either neat or in dilution at 1:10
or 1:100 in superfusion medium) or standard (over the range 0.5 to
64 ng/ml in superfusion medium) was added to 100 pi of antibody
104
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(R1/B3 as for in vivo assay, initial dilution 1:15,000; final
dilution 1:45,000) and 100 pi of tracer (corticosterone-3-(0-
carboxymethyl)-oxime-125 1-histamine 3000 counts per minute), both
in 0.5 molar phosphate assay-buffer. Assays were incubated in
plastic LP3 tubes (Luckhams Ltd, UK) overnight at 4°C prior to
separation with 1 ml dextran-coated charcoal and centrifuged (MSE,
Coolspin, Fisons, UK) at 2000 g at 4°C for 15 minutes. The super¬
natant was aspirated, discarded and the remaining pellet, unbound
(free) tracer, was counted in a gamma counter (LKB-Wallac, UK).
Profiles of intra- and inter-assay precision are illustrated
in figure 2.27. Over the working range 0.5 to 16 mg/ml the intra-
and inter-assay precisions are are respectively 4.5% and 17.2% at
0.5 ng/ml and 8.5% and 20% at 16 ng/ml. The working range was
usually determined by the limits 90-10% B/BQ (see figure 2.28 for a
typical standard curve) as well as the precision profile.
Double dilution of samples in superfusion medium produced
dilutional curves parallel to the standard curve (Fig 2.28) and
cross-reactivities (Fig 2.29) with possible interfering steroids
are in close agreement with those previously published with
significant cross-reactivity to 11-deoxycorticosterone (0.7%).
Recovery of corticosterone (observed) from superfusion medium
is close to that expected (Fig 2.30).
2.2.5.6: Preparation of tracers
Tracers for 17p(-hydroxyprogesterone, androstenedione, testo¬
sterone and corticosterone assays were prepared by coupling the
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steroid-3-(-0-carboxymethyl)-oxime with ^5j_histamine by the
ehloramine-T technique (Greenwood, 1963). Iodination of the
steroid took place in three stages in a fume cupboard:
i) Steroid activation
200 jig of steroid-3-(-0-carboxymethyl)-oxime (Steraloids, UK)
was dissolved in 100 pi of dioxan in a glass tube prior to the
addition of 10 jul tri-n-butylamine (20% in dioxan v/v) and 10 pi
isobutylchlorformate (10% in dioxan v/v) (reagents BDH, UK). The
mixture was vortexed and incubated for 30 minutes on ice to
maintain a constant temperature between 8-10°C.
ii) Iodination of histamine
1 mCi ^5i_sodium (Amersham pic, UK) was mixed, using a
pipette for 45 seconds, with 10 pi histamine solution (0.22 mg/ml
in 0.5 molar phosphate buffer, pH8.0) and 10 pi chloramine-T
solution (0.5 mg/ml in distilled water) in a conical glass tube
prior to the addition of 10 pi sodium metabisulphite (30 mg/ml in
distilled water) (reagents BDH, UK).
iii) Conjugation
120 pi of the 'activated steroid' was made up to 250 pi with
dioxan and mixed with a pipette. 50 pi of the 'activated steroid'
is taken and added to the ^25i_histamine, mixed prior to the
addition of 10 pi of 0.1 molar sodium hydroxide and incubated on
ice at 0°C for approximately 1 hour.
After incubation 900 of 0.1 molar hydrochloric acid and 1
ml ethyl ether were added to the mixture, vortexed and the organic







Figure 2.31: Thin layer chromatography of steroid-3-CMO-^5x_
histamine - the active band is shaded.
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aspirated and discarded into a suitable container for radioactive
waste. 900 pi of 0.1 molar hydrochloric acid was added to the
remaining aqueous layer, vortexed prior to the addition of 1 ml 0.5
molar phosphate buffer (pH 7.0) and 800 pi ethyl acetate and
vortexed again. The organic and aqueous phases were allowed to
separate over 10 minutes and the aqueous layer was aspirated and
discarded into a suitable container for radioactive waste. The
organic layer was further dried with the addition of anhydrous
sodium sulphate (reagents BDH, UK).
The organic phase was spotted on to a TLC plate (200 x 200 mm
aluminium precoated with 0.2 mm Silica gel 60, Merck, West Germany)
and the products separated by thin layer chromatography using a
mixture of chloroform: methanol: glacial acetic acid (90:10:1).
The separation was run until the solvent front was just within the
top of the plate, the plate dried in air and the radioactive bands
detected by exposing the plate to X-ray film (NMB, Kodak-Pathe,
France) for 30 minutes in a dark room. The film was developed and
the appropriate band identified, removed and eluted overnight at
4°C in absolute alcohol. After TLC two bands of iodinated material
are detectable and it is the lower band that contains the prepared
tracer (Fig 2.32). Average yield was approximately 30 to 50%.
2.2.5.7: Preparation of dextran-coated charcoal
Dextran-coated charcoal was used for separation of androstene-
dione, testosterone and corticosterone assays and contained:
0.8 g gelatin (0.04% w/v) (Sigma Chemicals, USA)
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1.2 g dextran T 70 (0.06% w/v) (Pharmacia Chemicals, Sweden)
12 g activated charcoal (0.6% w/v) (Sigma Chemicals, USA)
Gelatin was dissolved in heated 0.1 molar phosphate buffer,
allowed to cool, mixed with dextran and activated charcoal, and
made up to a final volume of 2 litres with 0.1 molar phosphate
buffer.
2.2.5.8: Reproducibility characteristics of the multichannel
superfusion-system
The coefficient of variation in flow rate (mean flow rate
divided by standard deviation of the mean and expressed as
percentage) was 1.5% (n = 10 columns) at 0.5 ml per minute. The
between-column coefficient of variation in steroidogenesis (mean
steroid concentration divided by the standard deviation of the mean
and expressed as percentage) was obtained for a mixed population of
adrenal and testicular cells by estimating each steroid concen¬
tration in the eluate from 10 parallel columns containing the same
number of cells and treated with the same stimuli (ACTH over the
dose range 1-100 pg/ml). This therefore takes into account error
due to flow rate, loading the equivalent number of cells into each
column and intra-assay precision. The respective values for
progesterone, 17pV-hydroxyprogesterone, androstenedione, testo¬
sterone and corticosterone are 25.1, 34.2, 32.4, 20.3 and 15.4%.
2.2.5.9: Statistics
To permit direct comparison of changes in steroid hormone
113
concentrations between experiments and between cell populations,
responses were converted to the natural logarithm (In) transforming
data to a normal distribution (Feek, 1980) and analysed by
Students' t-test. Data was processed by a BBC microcomputer
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3.1: Introduction
The aim of these studies is to develop an in vivo model that
demonstrates a possible interaction between the adrenal and the
gonad in the male rat. The adrenal gland may secrete steroid
precursors that can be used either directly by the testis in the
secretion of testosterone or indirectly via the secretion of
anterior pituitary LH. Previous studies (Kniewald, 1971; Kalra,
1977; Lescoat, 1982; Lescoat, 1984) have employed adrenalectomy as
a model for the investigation of an interaction between the adrenal
and testis. However, there are difficulties in the interpretation
of these experiments.
i) In acute studies it is difficult to differentiate any
effect that adrenalectomy may have upon plasma testosterone
concentrations from the concomitant effect of surgical stress.
ii) Whilst chronic studies avoid this problem, it is
difficult to differentiate any direct effect that adrenalectomy may
have upon plasma testosterone concentrations from the debilitating
effects of chronic glucocorticoid insufficiency. Furthermore, in
any chronic study, resetting of anterior pituitary-gonadal
relationships may mask the absence of any contribution made by the
adrenal gland to testicular steroidogenesis.
Despite these reservations it has been shown that
adrenalectomy prevents normal pubertal development (Lescoat, 1982),
abolishes the circadian rhythm of testosterone secretion (Kalra,
1977) and reduces the stress-mediated rise in plasma testosterone
concentrations when compared with sham-operated controls (Lescoat,
116
1984). In contrast, others have failed to demonstrate any effect
of adrenalectomy on the plasma testosterone levels (McNeilly,
1980). Whilst results obtained from these experiments would appear
to indicate that the adrenal gland may influence testicular
steroidogenesis, they are inconsistent and difficult to interpret.
The first set of experiments is designed to determine whether
adrenalectomy does influence the testicular secretion of
testosterone, and, if so, its mechanism.
3.2.1: The acute and chronic effects of adrenalectomy on plasma
testosterone levels in the male rat
Adrenalectomy, sham adrenalectomy and gonadectomy were
performed in male rats at 55 days of age under halothane
anaesthesia. Postoperatively, adrenalectomised rats were
maintained on saline 0.9% (w/v) ad libitum, whereas sham-operated
and castrated animals were maintained on tap water. Blood was
obtained for steroid assays by decapitation at the time intervals
indicated (n = 3 animals per group at each time interval). Any
changes in body weight, plasma corticosterone levels or plasma
testosterone levels are illustrated in figures 3.1, 3.2 and 3.3
respectively.
i) Sham-adrenalectomised animals gained weight more rapidly
than either castrated or adrenalectomised rats confirming previous
studies (Lescoat, 1982). This presumably results from increased
muscle protein breakdown and decreased protein synthesis caused by




















Figure 3.1: Mean +_ SE body weight (g) at sacrifice following
adrenalectomy, sham adrenalectomy or gonadectomy in intact male
rats.
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Figure 3.2: Mean _+ SE plasma corticosterone levels (ng/ml)
following adrenalectomy, sham adrenalectomy or gonadectomy in
intact male rats.
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Figure 3.3: Mean +_ SE plasma testosterone levels (ng/ml) following
adrenalectomy, sham adrenalectomy or gonadectomy in intact male
rats.
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Alegre, 1980). If weight gain is any index of general well-being,
the plasma testosterone response to adrenalectomy observed in
previous studies (Kalra, 1977; Leseoat, 1982; Lescoat, 1984) may
merely reflect the indirect effects of chronic adrenal
insufficiency.
ii) Whilst there was a rise in plasma corticosterone levels
following surgery in both sham-adrenalectomised and gonadectomised
animals, there was no difference in the plasma corticosterone
levels between the two groups. Bilateral adrenalectomy reduced
plasma corticosterone concentrations as expected.
iii) No difference in plasma testosterone levels was observed
between adrenalectomised and sham-adrenalectomised animals.
Castration successfully reduced plasma testosterone concentrations
as expected. This data conflicts with the results of previous
studies (Kniewald, 1971; Lescoat, 1982). However, the small number
of animals employed in the present study may explain the failure to
achieve a significant difference in the plasma testosterone
concentrations between the groups of animals. Unfortunately, small
numbers of animals were necessary to permit accurate timing of the
frequent samples that were generated in the early stages of the
experiment.
For these reasons the experiment was extended to involve a
larger number of animals, by assessing the plasma testosterone
response to either adrenalectomy or sham adrenalectomy at 2 and 7
days following each procedure and compared with intact controls.
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3.2.2: Plasma testosterone and corticosterone concentrations at 2
days following adrenalectomy and sham adrenalectomy In the male rat
Adrenalectomy and sham adrenalectomy were performed in 55-day-
old male rats under halothane anaesthesia and compared with intact
controls. Postoperatively, adrenalectomised rats were maintained
on saline 0.9% (w/v) ad libitum whereas sham-operated and control
animals were maintained on tap water. All experimental animals (n
= 10 or 11 in each group) were left to recover from the effects of
anaesthesia for 2 days before blood sampling by decapitation at
1100 h. Plasma corticosterone concentrations, plasma testosterone
concentrations and body weight at death are illustrated in figure
3.4. Statistical significance of any changes in these parameters
between the operated animals when compared with intact controls was
assessed by Wilcoxon test.
i) Plasma corticosterone concentrations were significantly
reduced in animals undergoing bilateral adrenalectomy (all levels
undetectable, p <0.0005) but not in animals undergoing sham
operation (mean +_ SE 157.5 _+ 39.4 ng/ml, p not significant) when
compared with unoperated controls (mean _+ SE 121.9 _+ 39.4 ng/ml).
ii) Plasma testosterone concentrations were significantly
reduced in animals undergoing bilateral adrenalectomy (mean +_ SE
1.16 _+ 0.2 ng/ml, p <0.05) and sham adrenalectomy (mean +_ SE 1.14 +_
0.2 ng/ml, p <0.05), when compared with intact controls (mean _+ SE
2.56 +_ 0.6 ng/ml). Hoewever, there was no difference in the plasma











































Figure 3.4: Mean +_ SE plasma corticosterone levels (ng/ml),
testosterone levels (ng/ml) and body weight (g) at 2 days following
adrenalectomy and sham adrenalectomy in male rats when compared
with intact controls.
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iii) Body weights were comparable in each group.
These results are consistent with a non-specific effect of
stress and general anaesthesia producing a depression of testicular
testosterone secretion.
3.2.3: Plasma testosterone and corticosterone concentrations at 7
days following adrenalectomy and sham adrenalectomy in the male rat
Adrenalectomy and sham adrenalectomy were performed in 39-day-
old male rats under halothane anaesthesia and compared with intact
controls. Postoperatively, adrenalectomised rats are maintained on
saline 0.9% (w/v) ad libitum. All experimental animals (n = 6 in
each group) were left to recover from the effects of anaesthesia
for 7 days before blood sampling by decapitation at 1100 h. Plasma
corticosterone concentrations, plasma testosterone concentrations
and body weight at death are illustrated in figure 3.5. Statisti¬
cal significance of any changes in these parameters between the
operated animals when compared with intact controls was assessed by
Wilcoxon test.
i) Plasma corticosterone concentrations were significantly
reduced in animals undergoing bilateral adrenalectomy (all levels
undetectable, p <0.0005) but not in animals undergoing sham
operation (mean _+ SE 336.2 _+ 77.14 ng/ml, p not significant) when
compared with intact controls (mean +_ SE 295.7 _+ 12.1 ng/ml).
ii) Plasma testosterone concentrations were not significantly
reduced in animals undergoing bilateral adrenalectomy (mean _+ SE














































Figure 3.5: Mean +_ SE plasma corticosterone levels (ng/ml),
testosterone levels (ng/ml) and body weight (g) at 7 days following
adrenalectomy and sham adrenalectomy in male rats when compared
with intact controls.
125
(mean + SE 1.75 +_ 0.3 ng/ml, p not significant) when compared with
intact controls (mean _+ SE 1.8 _+ 0.3 ng/ml).
iii) Body weights were comparable in each group.
These results are consistent with the amelioration of the non¬
specific effect of stress and general anaesthesia by testicular
testosterone secretion.
In the male rat, during the acute response to stress (30-90
minutes), there is a rapid rise in the anterior pituitary secretion
of LH, prolactin and ACTH that is accompanied by a progressive
increase in the secretion of corticosterone by the adrenal gland
and testosterone by the testis (Euker, 1975; Lorenzen, 1980).
However, in the chronic phase (4-48 hours) of stress, there is a
profound suppression of the pituitary-gonadal axis resulting in the
suppression of the anterior pituitary secretion of LH and
testicular secretion of testosterone (Free, 1973; Lorenzen, 1980;
Childs, 1983; Ringstrom, 1984; Stahl, 1984). These changes may be
mediated either by the direct action of stress on the hypothalamus
and/or by the increased secretion of adrenal corticosteroids
(Ringstrom, 1984; Mann, 1985). The latter is supported by the
finding that the administration of pharmacological doses of
glucocorticoid can achieve a similar inhibition of plasma LH and
testosterone concentrations (Desjardins, 1971; Stahl, 1984;
Ringstrom, 1984).
The administration of pharmacological doses of glucocorticoids
to male rats was therefore used as a suitable model to study the
influence of the adrenal gland on testicular steroidogenesis by
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permitting suppression of the pituitary-adrenal axis as well as
pituitary-gonadal axis. Subsequent stimulation of the suppressed
adrenal gland with ACTH will determine whether the adrenal can
provide steroid precursors that can either be utilised by the
testis in the secretion of testosterone directly or indirectly by
stimulation of anterior pituitary gonadotrophs.
3.2.4: The effect of dexamethasone suppression on plasma
testosterone levels in the male rat
Adequate suppression of the pituitary-gonadal axis has been
previously achieved with pharmacological doses of glucocorticoid
employing dexamethasone 10-1000 jag daily for 5 days (Saez, 1977;
Bambino, 1981; Stahl, 1984), corticosterone 3.0 mg daily for 5 days
and Cortisol 100 mg by implantation for a 4 day period (Ringstrom,
1984). The use of dexamethasone has the advantage of being a
synthetic glucocorticoid with little cross-reactivity with the
assays employed in this study. Preliminary experiments (data not
shown) have shown that an oral regimen of dexamethasone 100 ^ag at
0900, 1700 and 2300 h on the day before the study and again at 0900
h on the day of study achieves adequate suppresssion of both plasma
corticosterone and testosterone levels.
Dexamethasone was administered to male rats aged 39 days old
(n = 6) and plasma corticosterone and testosterone levels are
compared with untreated controls (n = 6). Blood for steroid
hormone analysis was obtained by decapitation at 1100 h. Plasma











































Figure 3.6: The effect of dexamethasone suppression on plasma
corticosterone (ng/ml), plasma testosterone levels (ng/ml) and body
weight (g) on male rats when compared with untreated controls.
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and body weight at death are illustrated in figure 3.6. Statisti¬
cal significance of any changes in these parameters between treated
animals when compared with untreated controls was assessed by
Wilcoxon test.
i) Plasma corticosterone concentrations were significantly
reduced in animals treated with dexamethasone (mean + SE 5.7 +_ 2.4
ng/ml, p <0.0005) compared with untreated controls (mean _+ SE 295.7
_+ 12.1 ng/ml).
ii) Plasma testosterone concentrations were significantly
reduced in animals treated with dexamethasone suppression (mean +_
SE 0.92 +_ 0.2 ng/ml, p <0.05) when compared with untreated controls
(mean +_ SE 1.8 + 0.3 ng/ml).
iii) Body weights were comparable in each group.
These results demonstrate suppression of both pituitary-
adrenal and pituitary-gonadal axes with pharmacological doses of
glucocorticoid. Dexamethasone was then administered to castrated
male rats in order to assess whether its action is mediated by
suppression of the anterior pituitary secretion of LH or by direct
effects upon the testis.
3.2.5: The effect of dexamethasone suppression on the anterior
pituitary secretion of LH in castrated male rats
In order to determine the effect of pharmacological doses of
glucocorticoid on anterior pituitary LH secretion, male rats of 55
days of age were castrated under halothane anaesthesia and allowed





































































Figure 3.7: Plasma LH, eorticosterone and testosterone levels
castrated, untreated male rats when compared with dexamethasone
suppressed, castrated animals and untreated, intact controls.
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water or dexamethasone 100 jag at 0900, 1700 and 2300 h on the day
before the study and again at 0900 h on the day of study and
compared with intact and untreated controls. Blood for steroid
hormone analysis was obtained by decapitation at 1100 h.
Statistical significance of any changes in plasma corticosterone,
testosterone and LH concentrations between untreated, castrated
animals (n = 10) when compared with dexamethasone-treated,
castrated animals (n = 9) and untreated intact, controls (n = 10)
was assessed by Wilcoxon test. Results are illustrated in figure
3.7.
i) There was a significant elevation of plasma LH concen¬
trations following castration in untreated animals (mean _+ SE 165.9
_+ 27.0 ng/ml) when compared with untreated, intact controls (mean _+
SE 15.1 ± 14.7 ng/ml, p <0.0005). However, the rise in plasma LH
levels in response to castration was significantly reduced in
dexamethasone-treated, animals (mean +_ SE 97.0 _+ 37.3 ng/ml, p
<0.0005) when compared with untreated animals.
ii) Castration reduces testosterone levels to below the level
of detection in both groups when compared with intact controls
(mean +_ SE 3.6 +_ 0.9 ng/ml, p <0.0005).
iii) The administration of dexamethasone to castrated animals
reduces plasma corticosterone levels (undetectable, p <0.0005) when
compared with their untreated castrated counterparts (mean SE 173
+_ 32 ng/ml) and untreated, intact controls (mean + SE 185.2 _+ 38
ng/ml).
This experiment confirms previous studies demonstrating
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suppression of the pituitary-gonadal axis in male rats with
pharmacological doses of glucocorticoid (Smith, 1971; Baldwin,
1974; Baldwin, 1979; Stahl, 1984; Ringstrom, 1984).
3.2.6 The effect of ACTH over the dose range 0.01-10 pg on intact,
dexamethasone-suppressed male rats when compared with intact,
untreated controls
In order to determine the optimal dose of intraperitoneal ACTH
necessary to achieve plasma corticosterone and testosterone concen¬
trations in dexamethasone-treated animals comparable with untreated
controls, either water (untreated controls, n = 10) or dexametha-
sone 100 pg at 0900, 1700 and 2300 h was administered orally on the
day before the study and again at 0900 h on the day of study, and
saline (n = 10) or ACTH was administered intraperitoneally over the
dose range 0.1-10 pg (n = 10 in each group) to dexamethasone-
suppressed male rats aged 50 days at 1000 h and blood collected for
steroid hormone analysis by decapitation at 1100 h. Preliminary
studies (data not shown) showed an increase in both plasma
corticosterone and testosterone concentrations at 60 minutes
following the intraperitoneal injection of ACTH but the concen¬
trations of these plasma steroids declined shortly thereafter.
Plasma corticosterone concentrations, plasma testosterone
concentrations, plasma progesterone concentrations and body weight
at death in response to ACTH over the dose range are illustrated in
figure 3.8. Statistical significance of any changes in any of
these parameters in treated animals when compared with untreated
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Figure 3.8: The effect of ACTH in dexamethasone-suppressed, intact
male rats on plasma corticosterone (ng/ml), plasma testosterone
levels (ng/ml), plasma progesterone levels (ng/ml) and body weight
(g) when compared with untreated, intact controls.
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controls was assessed by Wilcoxon test.
i) Plasma cortlcosterone concentrations were significantly
reduced in animals treated with dexamethasone alone (mean _+ SE 17.0
+_ 5.0 ng/ml, p <0.005), in animals treated with dexamethasone and
ACTH 0.01 pg (mean _+ SE 16.9 +_ 3.2 ng/ml, p <0.01) but not with
animals treated with dexamethasone and ACTH 0.1 jig (mean _+ SE 30.8
_+ 10.2 ng/ml, p not significant), ACTH 1.0 jig (mean +_ SE 38.5 +_
11.3 ng/ml, p not significant) and ACTH 10 ug mean _+ SE 110.2 60
ng/ml, p not significant) when compared with untreated, intact
controls (mean + SE 93.3 _+ 26.6 ng/ml).
ii) Plasma testosterone concentrations were significantly
reduced in animals treated with dexamethasone alone (mean +_ SE 1.4
■+ 0.3 ng/ml, p <0.05), in animals treated with dexamethasone and
ACTH 0.01 jug (mean +_ SE 1.5 +_ 0.4 ng/ml, p <0.05) but not with
animals treated with dexamethasone and ACTH 0.1 jug (mean _+ SE 1.8 _+
0.4 ng/ml, p not significant), ACTH 1.0 jug (mean +_ SE 2.4 +_ 0.7
ng/ml, p not significant) and ACTH 10 jag/ml (mean _+ SE 2.6 +_ 0.9
ng/ml, p not significant) when compared with untreated controls
(mean +_ SE 3.1 _+ 0.7 ng/ml).
iii) Plasma progesterone concentrations were not
significantly different in animals treated with dexamethasone alone
(mean +_ SE 0.5 +_ 0.16 ng/ml, p not significant), and ACTH 0.01 jag
(mean _+ SE 0.5 _+ 0.07 ng/ml, p not significant), in animals treated
with dexamethasone and ACTH 0.1 jig (mean _+ SE 1.5 ±_ 1.1 ng/ml, p
not significant), but increased in animals treated with
dexamethasone and ACTH 1.0 jug (mean _+ SE 2.3 +_ 1.4 ng/ml, p <0.05)
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and ACTH 10 y.g/ml (mean _+ SE 6.2 _+ 2.2 ng/ml, p <0.05) when
compared with untreated, intact controls (mean _+ SE 0.5 +_ 0.16
ng/ml).
Thus the administration of ACTH 10 #ug to dexamethasone-
suppressed rats is able to restore plasma corticosterone and plasma
testosterone to levels similar to those found in untreated
controls, whereas plasma progesterone exceeds those found in
untreated controls, although well within the normal range of 1-25
ng/ml described by other authors (Lorenzen, 1980). There may be,
therefore, some dissociation of adrenal steroidogenesis in response
to ACTH by the dexamethasone-suppressed adrenal. Nevertheless,
restoration of plasma testosterone concentrations by the
administration of ACTH implies that an adrenal product may increase
plasma testosterone levels.
In order to demonstrate that the source of increased secretion
of testosterone in response to ACTH is due to the adrenal secretion
of a product that is capable of stimulating testicular steroido¬
genesis, the plasma testosterone response to ACTH was studied in
the following groups:
i) dexamethasone-suppressed, castrated rats
ii) dexamethasone-suppressed, adrenalectomised rats
iii) dexamethasone-suppressed, intact rats
and compared with untreated, intact rats.
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3.2.7: The plasma progesterone, cortioosterone, testosterone and
LH responses in castrated, dexamethasone-suppressed male rats
treated with and without ACTH (10 jag) when compared with intact,
untreated controls
In order to determine whether the adrenal gland secretes
significant amounts of testosterone, the effect of dexamethasone
suppression (100 jag 8 hourly for 24 hours) upon plasma testosterone
levels in castrated animals, with (n = 14) and without (n = 15)
ACTH stimulation (10 jag intraperitoneally), was compared with those
of intact, untreated controls (n = 15). Data pooled from three
separate experiments is illustrated in figure 3.9 and statistical
significance of any changes of the parameters was assessed by
Wilcoxon test.
i) The administration of dexamethasone to castrated rats
significantly depressed both plasma corticosterone (mean _+ SE 7.5 +_
2.3 ng/ml) and progesterone (mean _+ SE 0.63 _+ 0.05 ng/ml) levels
when compared with untreated, intact controls (mean _+ SE plasma
corticosterone 222 18.5 ng/ml, p <0.001 and mean +_ SE plasma
progesterone 5.8 +_ 1.6 ng/ml, p <0.001), whereas the administration
of dexamethasone plus ACTH to castrated rats significantly
increased both plasma corticosterone (mean + SE 117.6 _+ 20.4 ng/ml,
p <0.001) and plasma progesterone levels (mean _+ SE 2.5 +_ 0.09
ng/ml, p <0.001) when compared with castration and dexamethasone
alone.
ii) In castrated, dexamethasone-suppressed rats, plasma






























































































Figure 3.9: Mean +_ SE body weight (g), plasma corticosterone
(ng/ml), plasma progesterone (ng/ml), plasma testosterone (ng/ml)
and plasma LH (ng/ml) concentrations in castrated rats treated with
dexamethasone when compared to castrated animals, treated with
dexamethasone and ACTH, and compared with intact, untreated
controls.
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significantly elevated (mean +_ SE plasma LH 82.6 _+ 5.9 ng/ml) when
compared with untreated, intact controls (mean _+ SE plasma testo¬
sterone 4.44 +_ 2.7 ng/ml, p <0.001 and mean _+ SE plasma LH 13.1 _+
2.4 ng/ml, p <0.001) but both plasma testosterone (undetectable, p
not significant) and plasma LH concentrations (mean +_ SE 101.6 +_
7.0 ng/ml, p not significant) failed to change in castrated
dexamethasone-suppressed rats following the administration of ACTH
when compared with castration and dexamethasone alone.
iii) Body weights were not significantly different in the
three groups.
Whilst castration lowers plasma testosterone levels and
elevates plasma LH levels as expected, ACTH stimulation of
dexamethasone-suppressed castrated animals increases the adrenal
secretion of corticosterone and progesterone but the adrenal gland
does not secrete significant amounts of testosterone in vivo.
3.2.8: The plasma progesterone, corticosterone, testosterone and
LH responses in adrenalectomised, dexamethasone-suppressed male
intact, untreated controls
In order to determine whether pharmacological doses of gluco¬
corticoid inhibit and whether ACTH directly stimulates testicular
steroidogenesis, the effect of dexamethasone suppression (100 jag 8
hourly for 24 hours) upon plasma testosterone and LH levels in
adrenalectomised animals, with (n = 12) and without (n = 12) ACTH
stimulation (10 jig intraperitoneally), was compared with intact,






















































































































Figure 3.10: Mean +_ SE body weight (g), plasma corticosterone
(ng/ml), plasma progesterone (ng/ml), plasma testosterone (ng/ml)
and plasma LH (ng/ml) concentrations in adrenalectomised rats
treated with dexamethasone when compared to adrenalectomised
animals treated with dexamethasone and ACTH (10 jig, ip) and intact,
untreated controls.
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untreated controls (n = 12). Data pooled from three separate
experiments is illustrated in figure 3.10 and statistical
significance of any changes in the parameters was assessed by
Wilcoxon test.
i) In adrenalectomised rats dexamethasone suppression
significantly reduced both plasma testosterone (mean SE 0.6 ^
0.15 ng/ml, p <0.05) and plasma LH levels (mean +_ SE 6.4 +_ 0.2
ng/ml) when compared with untreated, intact controls (mean +_ SE
plasma testosterone 2.2 _+ 0.6 ng/ml, p <0.05 and mean +_ SE plasma
LH 29.6 + 5.2 ng/ml, p <0.01).
Thus, pharmacological doses of glucocorticoid inhibit
testicular steroidogenesis by suppressing the pituitary-gonadal
axis in the male rat in vivo.
ii) The administration of ACTH to adrenalectomised,
dexamethasone-suppressed rats failed to reverse the fall in either
plasma corticosterone (undetectable, p <0.0005), plasma
progesterone (mean +_ SE 0.3 +_ 0.02 ng/ml, p not significant) or
plasma testosterone levels (mean _+ SE 0.5 +_ 0.12 ng/ml, p not
significant) when compared with adrenalectomised animals treated
with dexamethasone alone (plasma corticosterone undetectable, mean
+_ SE plasma progesterone 0.4 +_ 0.03 ng/ml and mean +_ SE plasma
testosterone 0.6 _+ 0.15 ng/ml).
Thus, ACTH does not stimulate testicular steroidogenesis
directly in the male rat in vivo.
iii) Body weights were not significantly different in the
three groups.
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3.2.9: The plasma progesterone, corticosterone, testosterone and
LH responses in intact, dexamethasone-suppressed rats treated with
and without ACTH (10 ^ig) when compared with intact, untreated
controls
In order to determine whether the adrenal gland may contribute
either directly or indirectly to testicular steroidogenesis, the
effect of dexamethasone suppression (100 ^ag 8 hourly for 24 hours)
upon plasma testosterone and LH levels in intact animals, with (n =
27) and without (n = 27) ACTH (10 pg intraperitoneally), was
compared with intact, untreated controls (n = 27). Data pooled
from three separate experiments is illustrated in figure 3.11 and
statistical significance of any changes in the parameters was
assessed by Wilcoxon test.
i) In intact animals, the administration of dexamethasone
significantly reduced both plasma corticosterone (mean +_ SE 14.0 +_
3.0 ng/ml), plasma testosterone (mean _+ SE 1.6 +_ 0.3 ng/ml) and
plasma LH (mean + SE 8.0 0.8 ng/ml) but not plasma progesterone
levels (mean _+ SE 0.64 _+ 0.09 ng/ml) when compared with untreated
controls (mean +_ SE plasma corticosterone 88.5 _+ 16.3 ng/ml, p
<0.001, mean _+ SE plasma testosterone 3.7 +_ 0.7 ng/ml, p <0.001,
mean _+ SE plasma LH 17.2 +_ 2.8 ng/ml and mean _+ SE plasma
progesterone 0.72 _+ 0.09 ng/ml, p not significant).
ii) In contrast, the administration of ACTH to intact,
dexamethasone-suppressed animals significantly increased plasma
corticosterone (mean _+ SE 168.8 _+ 29.4 ng/ml, p <0.001) plasma































































































Figure 3.11: Mean +_ SE body weight (g), plasma eortieosterone
(ng/ml), plasma progesterone (ng/ml), plasma testosterone (ng/ml)
and plasma LH (ng/ml) concentrations in intaet rats treated with
dexamethasone when compared with intact animals treated with
dexamethasone and ACTH (10 pg, ip) and intact, untreated controls.
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testosterone (mean 2.4 +_ 0.6 ng/ml, p <0.05) but not plasma LH
levels (mean _+ SE 15.1 +_ 1.1 ng/ml, p not significant) when
compared with intact animals treated with dexamethasone alone.
iii) Body weights were not significantly different in the
three groups.
Thus, the adrenal gland contributes to testicular steroido¬
genesis in the rat in vivo. Since increased testosterone secretion
in response to ACTH is not associated with a significant change in
plasma LH levels it would appear that the adrenal stimulation of
the testis is mediated by direct means rather than indirectly by
means of the pituitary-gonadal axis.
It is clear from this in vivo model that there is some
evidence to support the concept that the adrenal gland may secrete
steroid precursors that can stimulate the testicular secretion of
testosterone. Parallel in vitro studies have implicated a role for
progesterone as agents directly in the mediation of adrenal »
gonadal interactions (see section 4). Progesterone was therefore
administered to dexamethasone-suppressed rats, in doses to achieve
physiological plasma progesterone concentrations, in order to
determine whether progesterone can acutely stimulate the testicular
secretion of testosterone.
3.2.10 The effect of the administration of progesterone (100 pg,
so) or saline on plasma corticosterone, plasma progesterone and
plasma testosterone levels in intact, dexamethasone-suppressed
animals when compared with intact, untreated controls
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In initial studies, the administration of progesterone to
dexamethasone-suppressed animals in doses up to 100 jig by the
intraperitoneal route failed to achieve any significant elevation
of plasma progesterone concentrations (all levels undetectable,
data not shown) and consequently failed to achieve a change in
plasma testosterone levels (data not shown). Presumably either the
absorption of progesterone by this route is inadequate or
presystemic metabolism by the liver is such to prevent any
significant quantities of progesterone from entering the
circulation. In subsequent experiments, progesterone was
administered by the subcutaneous route and preliminary experiments
(data not shown) demonstrate that a subcutaneous injection of 100
pg achieves plasma progesterone concentrations that are within the
physiological range.
In three separate experiments, either water (untreated, intact
controls) or dexamethasone 100 jig at 0900, 1700 and 2300 h was
administered orally on the day before the study and again at 0900 h
on the day of study and either progesterone (100 jig) or saline was
administered subcutaneously to dexamethasone-suppressed, intact
male rats aged 50 days at 1000 h and blood collected for steroid
hormone analysis by decapitation at 1100 h. Statistical
significance of any changes in parameters in pooled data between
intact animals treated with dexamethasone alone (n = 39) when
compared with intact animals treated with dexamethasone and
progesterone (n = 39) and untreated, intact controls (n = 39) was




































igure 3.12: Plasma corticosterone, plasma progesterone and plasma
estosterone levels in intact rats treated with dexamethasone when
ompared with intact animals treated with dexamethasone and
rogesterone intact, untreated controls.
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3.12.
i) In intact animals, the administration of dexamethasone
significantly reduced both plasma corticosterone (not detectable),
plasma testosterone (mean _+ SE 1.7 +_ 0.2 ng/ml) and plasma
progesterone (mean _+ SE 1.4 +_ 0.01 ng/ml) levels when compared with
intact, untreated controls (mean +_ SE plasma corticosterone 164.4 _+
26.9 ng/ml, p <0.001, mean +_ SE plasma testosterone 2.6 _+ 0.2
ng/ml, p <0.05, and mean _+ SE plasma progesterone 3.9 _+ 0.6 ng/ml,
p <0.001).
ii) In contrast, the administration of progesterone to
intact, dexamethasone-suppressed animals significantly increased
plasma progesterone (mean +_ SE 2.1 _+ 0.1 ng/ml, p <0.001) and
plasma testosterone (mean 2.2 +_ 0.2 ng/ml, p <0.05) but not plasma
corticosterone (not detectable, p not significant) levels when
compared with intact animals treated with dexamethasone alone.
iii) Body weights were not significantly different in the
three groups.
It is concluded that the administration of progesterone to
dexamethasone-suppressed male rats in doses achieving physiological
plasma progesterone concentrations stimulates the testicular
secretion of testosterone.
3.3: Discussion
This series of experiments illustrates the successful develop¬
ment of an in vivo model of adrenal » gonadal interactions in
the male rat. The action of adrenal steroids upon testicular
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steroidogenesis is complex; whilst the adrenal secretion of gluco¬
corticoid indirectly inhibits the testicular secretion of testo¬
sterone (by suppressing the anterior pituitary secretion of LH),
the adrenal secretion of progesterone directly stimulates the
testicular secretion of testosterone.
These studies confirm previous results in which the
administration of progesterone (10 mg in oil by injection) to
either intact, adrenalectomised or hypohpysectomised but untreated
male rats increased plasma testosterone concentrations at 6-8 hours
(Kalra, 1980). In both intact and adrenalectomised animals this
effect was mediated without altering plasma gonadotrophin levels.
In other studies the administration of progesterone to male rats,
either intact or castrated (with or without the prior adminis¬
tration of testosterone), demonstrated little influence on the
anterior pituitary secretion of LH (Brown-Grant, 1974; Aiyer, 1976;
Fink, 1977). Thus the ability of progesterone to stimulate
testicular steroidogenesis appears be mediated directly rather than
indirectly by stimulation of the anterior pituitary secretion of
LH.
The ability of the testis to metabolise exogenous progesterone
varies drastically during the sexual development and maturation of
the male rat. The addition of physiological concentrations of
progesterone to fetal testes in vitro stimulates testosterone
production (Habert, 1986). Testicular tissue of newborn rats in
vitro (1-10 days old) is able to convert 25-60% of progesterone to
androgens (principally testosterone) but this ability is lost (less
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than 1 % conversion) as the testes mature over the period 10-40 days
of age, only to return again in the fully mature animal (40%
conversion) (Steinberger, 1968). If the adrenal secretion of
progesterone is capable of stimulating testicular steroidogenesis
and the ability of the testis to respond to progesterone is limited
to certain periods of testicular maturation, these observations
would tend to suggest that the adrenal gland may have an important
role in the sexual development of the male rat. In male rats both
plasma progesterone and testosterone exhibit circadian rhythms that
are related to the photoperiod and adrenalectomy subsequently
abolishes these circadian rhythms (Kalra, 1977). Thus the adrenal
secretion of progesterone may exert profound effects on the daily
secretion of testosterone by the testis.
In the acute phase of stress (the first 90 minutes) there is a
rise in plasma LH and plasma testosterone concentrations which can
be ameliorated by prior adrenalectomy (Lescoat, 1984), suggesting
that the rise in plasma testosterone concentrations is, in part,
explained by the stress-related secretion of adrenal precursors
that stimulate testicular steroidogenesis. However, during the
chronic phase of stress (4 to 48 hours), plasma LH and testosterone
levels fall due to non-specific suppression of LH secretion that
may be partly explained by increased secretion of glucocorticoids




The significance of these in vivo findings is to provide
evidence in the male rat that:
i) the adrenal gland does not secrete significant amounts
of androgens or testosterone.
ii) the major part of androgen production is derived from
the testis.
iii) the administration of pharmacological doses of
glucocorticoid can suppress the hypothalamic-pituitary-
testicular axis.
iv) the adrenal can directly stimulate testicular steroido¬
genesis, and this is probably mediated by the secretion of
adrenal steroid precursors such as progesterone.
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Chapter 4
ADRENAL —► GONAD INTERACTIONS IN VITRO
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4.1: Introduction
The aim of these experiments is to develop an in vitro system
that illustrates a possible interaction between the adrenal and the
testis in the rat. Studies on isolated whole perfused testis have
provided much information on the biosynthetic pathways of the
testis (Chubb, 1979a; Chubb, 1979b) and studies involving the
isolated whole perfused adrenal have added to our knowledge of
adrenal steroidogenesis (Sibley, 1981). However, the preparation
of isolated cells permits a more readily accessible method of
studying possible hormonal interactions between the adrenal and the
testis.
Static incubation systems have been successfully used to
demonstrate the synthesis and secretion of hormones from endocrine
cells in vitro. Whilst this approach has the advantage of
simplicity, it does not necessarily provide an ideal method for the
investigation of cellular function (see sections 1.1.4 and 1.2.4).
In contrast, the superfusion system is a dynamic model for
hormone action. This system has been well described as a model for
adrenal steroidogenesis (Lowry, 1974) as well as testicular
steroidogenesis (Davies, 1979; Wu, 1985) and has previously been
used succesfully to study interactions between isolated cells
derived from the same organ (Bartlett, 1985). Whilst the
juxtaposition of adrenal and testicular cells in vitro does not
necessarily reflect the tight anatomical and functional arrangement
of cells that exists in vivo it does provide an opportunity to
explore of a direct interaction between the steroid-secreting cells
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isolated from the adrenal and testis.
4.1.1: Superfusion of isolated testicular cells with eluate
from stimulated adrenal cells
In one experiment, isolated adrenal cells (1 x 10® per column,
n = 2) were stimulated with ACTH (100 pg/ml) and the eluate was
then superfused through columns of isolated testicular cells (10 x
106 per column, n =2). Following stimulation of adrenal cells with
ACTH there was an increase in corticosterone secretion as expected,
but superfusion of the eluate through the isolated testicular cells
stimulated testosterone secretion (Fig 4.1), supporting the concept
that adrenal cells may contribute a product that can be utilised by
testicular cells for the purposes of steroidogenesis. The basis of
this preliminary experiment was therefore used for subsequent
experiments as a model for adrenal » gonad interactions. In
these experiments adrenal and testicular cells were mixed within
each column for technical convenience, to enable individual
experiments to be 'scaled-up' to employ 10 columns.
4.1.2: Response of a mixture of isolated adrenal and testicular
cells to ACTH over the dose range 1-100 pg/ml
Steroid responses to the administration of ACTH over the dose
range 1-100 pg/ml from a typical experiment are illustrated in
figures 4.2 to 4.6. The experiment used 10 parallel columns: six
columns consisted of a mixture of isolated adrenal (1 x 10^ per
column) and isolated testicular cells (10 x 10& per column),
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Figure 4.1: Mean testosterone (0 0) and cortlcosterone (• •)
responses to ACTH 100 pg/ml following the superfusion of eluate
from isolated superfused adrenal cells through isolated superfused




Figure 4.2: Mean +_ SE progesterone response to ACTH 1-100 pg/ml
by isolated superfused adrenal cells (® ®), testicular cells
(0 0) and a mixed cell population (@ ©). Each fraction
represents 5 minutes.
154











Figure 4.3: Mean +_ SE 17c\-hydroxyprogesterone responses to ACTH 1-
100 pg/ml by isolated superfused adrenal cells (@ ©), testicular
cells (0 0) and a mixed cell population (® ®). Each
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Figure 4.4: Mean +_ SE corticosterone responses to ACTH 1-100 pg/ml
by isolated superfused adrenal cells (® ©), testicular cells
(0 0) and a mixed cell population (9 9). Each fraction
represents 5 minutes.
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Figure 4.5: Mean _+ SE androstenedione responses to ACTH 1-100
pg/ml by isolated adrenal cells (© ©), testicular cells (0 0)
and a mixed cell population (® ®). Each fraction represents 5
minutes.
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Figure 4.6: Mean +_ SE testosterone responses to ACTH 1-100 pg/ml
by isolated superfused adrenal cells (• 9), testicular cells
(0 0) and a mixed cell population (® f). Each fraction
represents 5 minutes.
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two columns of isolated adrenal cells alone (1 x 10^ cells per
column) and two columns of isolated testicular cells alone (10 x
106 cells per column). Over the dose range employed there was a
dose-dependent secretion of progesterone (Fig 4.2), 17<s<-
hydroxyprogesterone (Fig 4.3) and corticosterone (Fig 4.4) from
isolated adrenal cells, with or without the juxtaposition of
testicular cells, whereas secretion of these hormones by testicular
cells alone was negligible. In addition there was a dose-dependent
secretion of androstenedione (Fig 4.5) and testosterone (Fig 4.6)
by the mixture of isolated adrenal and testicular cells that was
not seen when the two cell types were separate. Furthermore, the
juxtaposition of testicular with adrenal cells decreased the
concentrations of progesterone and corticosterone and increased the
concentrations of 17iX-bydroxyprogesterone.
4.1.3: Pooled data of isolated cell response to ACTH 100 pg/ml
The steroid responses to the administration of ACTH 100 pg/ml
were pooled from five consecutive experiments and analysed by
transforming the data to the natural logarithm (In) for the purpose
of statistical analysis by Student's t-test. The results are
illustrated in figures 4.7 to 4.11 (note the logarithmic scale).
The concentrations of 17(\-hydroxyprogesterone, androstenedione and
testosterone were significantly increased and the concentrations of
progesterone and corticosterone significantly reduced in the eluate
of the mixed cell population (n = 6 columns per experiment) when




Figure 4.7: Pooled data from 5 separate experiments illustrating
the progesterone response to ACTH 100 pg/ml by isolated superfused
adrenal cells (9 9), testicular cells (0 0) and a mixed cell





Figure 4.8: Pooled data from 5 separate experiments illustrating
the 170v-hydroxyprogesterone response to ACTH 100 pg/ml by isolated
adrenal cells (0 ©), testicular cells (0 0) and a mixed cell












Figure 4.9: Pooled data from 5 separate experiments illustrating
the eorticosterone response to ACTH 100 pg/ml by isolated adrenal
cells (© ©), testicular cells (0 0) and a mixed cell





Figure 4.10: Pooled data from 5 separate experiments illustrating
the androstenedione response to ACTH 100 pg/ml by isolated adrenal
cells (® ®), testicular cells (0 0) and a mixed cell popu¬








Figure 4.11: Pooled data from 5 separate experiments illustrating
the testosterone response to ACTH 100 pg/ml by isolated adrenal
cells (© ©), testicular cells (0 0) and a mixed cell popu¬
lation (©—©). (* = p <0.05, ** = P <0.005 and *** = p <0.0005).
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experiment). In contrast, secretion of these hormones by isolated
testicular cells alone (n = 2 columns per experiment) was
negligible. The stimulation of adrenal cells with ACTH increases
the synthesis and secretion of adrenal steroid precursors that can
directly stimulate testicular steroidogenesis. Furthermore, the
adrenal steroids responsible for the stimulation of testosterone
secretion must be those steroids secreted by the adrenal in the
early pathway of adrenal steroidogenesis, occurring before or at
the level of the synthesis of progesterone. The adrenal secretion
of progesterone stimulates the testicular secretion of 17iX-hydroxy-
progesterone > androstenedione » testosterone.
The reduction of corticosterone in the eluate of the mixed
cell population is an interesting observation that is perhaps a
little difficult to explain, other than preferential utilisation of
adrenal progesterone by juxtaposed testicular cells.
4.1.4: Response of isolated cells to progesterone and hCG
In order to determine whether the adrenal secretion of
progesterone may act as a hormone precursor for testicular
steroidogenesis, ACTH (100 pg/ml), hCG (50 ng/ml) and progesterone
(10 ng/ml) was administered to either isolated testicular cells
alone (n = 5 columns) or a mixture of isolated adrenal and
testicular cells together (n = 5 columns). The importance of
determining an in vitro response of testicular cells to hCG is to
demonstrate that the preparation of isolated testicular cells was
biologically viable with retention of LH-receptors following
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Figure 4.12: Mean +_ SE progesterone response to ACTH 100 pg/ml,
progesterone 10 ng/ml and hCG 50 ng/ml by isolated superfused
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Figure 4.13: Mean _+ SE 17crt-hydroxyprogesterone response to ACTH
100 pg/ml, progesterone 10 ng/ml and hCG 50 ng/ml by isolated
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Figure 4.14: Mean _+ SE eorticosterone response to ACTH 100 pg/ml,
progesterone 10 ng/ml and hCG 50 ng/ml by isolated superfused




Figure 4.15: Mean _+ SE androstenedione response to ACTH 100 pg/ml,
progesterone 10 ng/ml and hCG 50 ng/ml by isolated superfused











Figure 4.16: Mean _+ SE testosterone response to ACTH 100 pg/ml,
progesterone 10 ng/ml and hCG 50 ng/ml by isolated superfused
adrenal cells (• •) and mixed adrenal-testicular cell population
(® 0).
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collagenase digestion and that any response is not necessarily due
to destruction of membrane integrity by enzyme digestion ('leaky
cells'). The dose of hCG was chosen following work by Dr F C W Wu,
M R C Reproductive Biology Unit, Chalmers Street, Edinburgh, in
optimising the stimulation of isolated testicular cells in the
in vitro superfusion system to the administration of both LH and
hCG. Maximal stimulation of isolated testicular cells is usually
achieved by this dose of hCG. The dose of progesterone was chosen
to achieve similar concentrations of progesterone in the
superfusion medium to that following the stimulation of isolated
adrenal cells by ACTH 100 pg/ml. The results of a single
experiment are illustrated in figures 4.11 to 4.16. Both ACTH and
progesterone stimulated the secretion of 17cv-hydroxyprogesterone,
androstenedione and testosterone from the mixed cell population
when compared with isolated adrenal cells alone. In comparison,
concentrations of progesterone and corticosterone were reduced in
the eluate of the mixed cell population when compared with isolated
adrenal cells alone. This data supports the conversion of
progesterone by isolated rat testicular cells in vitro —17^4-
hydroxyprogesterone —androstenedione > testosterone.
However, the peak steroid response to the administration of
progesterone is less than that achieved with ACTH-stimulated cells
(mean +_ SE testosterone concentration 1.3 0.2 ng/ml for
progesterone-stimulated cells compared to 3.52 +_ 1.3 ng/ml for
ACTH-stimulated cells), despite a higher concentration of
progesterone achieved by the administration of progesterone (10
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ng/ml) when compared with that achieved by ACTH-stimulated cells
(3.66 _+ 1.33 ng/ml). The implication of this observation is that
if the adrenal secretion of progesterone is responsible for the
stimulation of testicular steroidogenesis, other adrenal steroid
precursors must be involved to achieve similar testosterone
concentrations as that by ACTH-stimulated cells. The adminis¬
tration of pregnenelone (10 ng/ml), 17-hydroxypregnenelone (10
ng/ml) and 1 1^-hydroxyprogesterone to isolated testicular cells
also stimulated the secretion of testosterone to concentrations
approximately three times that of basal values (data not shown).
Whilst the administration of progesterone to the isolated
mixed cell population stimulates testicular steroidogenesis, there
does not appear to be stimulation of adrenal steroidogenesis.
Further, the stimulation of isolated testicular cells in the
mixture does not appear to stimulate adrenal steroid production.
This implies that with the juxtaposition of isolated adrenal and
testicular cells in the superfusion system the direction of
adrenal-testicular cooperation is one-way from the adrenal »
testis. Alternatively, the amount of corticosterone secreted by
adrenal cells in the eluate is approximately 10 times the amount of
testosterone secreted in the eluate by testicular cells.
Therefore, on a molar basis, the amount of steroid precursor
required to produce a five-fold increase in testicular testosterone




The isolated cell superfusion approach has demonstrated a
direct interaction between steroid-secreting cells of the adrenal
and the testis by the close juxtaposition of cells in vitro. One
possible explanation for this response is the transfer of receptors
from one cell type to the other during the preparation of isolated
cells for in vitro use. Concentrated and purified LH-receptors
have been succesfully transferred to isolated adrenal cells
enabling them to respond to stimulation with LH by increased
secretion of corticosterone in vitro (Dufau, 1978). However, the
lack of response by testicular cells alone to the administration of
ACTH would make this an unlikely explanation of these results.
Previous studies attempting to demonstrate the influence of
the adrenal and its steroids over the testis in vitro have employed
a variety of methods:
i) Static incubations of isolated cells have failed to
demonstrate increased secretion of testosterone from a mixed cell
population of isolated adrenal and Leydig cells in response to ACTH
(Podesta, 1984). Similarly, the present study also failed to show
increased testosterone secretion from a mixed population of adrenal
and testicular cells in response to the administration of ACTH in
static incubations (data not shown). This presumably reflects the
disadvantages of static incubation when compared with the isolated
cell superfusion. The possible reasons for these discrepancies
have been previously discussed. However both Leydig and Sertoli
cells are able to metabolise progesterone to testosterone under
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these conditions (Hall, 1969; Tcholakian, 1978).
ii) Superfusion of purified isolated Leydig cells with
pregnenelone results in the conversion —► progesterone ► Tfc\-
hydroxyprogesterone » androstenedione » testosterone (Kiihn-
Velten, 1984), confirming the findings of the present study.
iii) Electrofusion of isolated cells produces a hybrid cell
line that secretes corticosterone (mean corticosterone 160 pg/tube)
in response to LH (10 iU/ml) and testosterone (mean testosterone
225 pg/tube) in response to ACTH (10 pM), whereas these isolated
cells alone fail to secrete significant amounts of either
corticosterone in response to LH, or significant amounts of
testosterone in response to ACTH (Podesta, 1984).
iv) Static incubation of whole glands have been successful in
demonstrating ACTH-mediated secretion of testosterone by the testis
only when fetal adrenals are incubated in the presence of fetal
testes and not when the two glands are separate (Warren, 1984b).
Whole glands are also able to convert progesterone to testosterone
in vitro (Steinberger, 1968).
There is therefore significant support for the idea that the
adrenal secretion of steroid precursors may act as substrates for
synthesis of testosterone by rat testicular Leydig cells in vitro.
That the testis can metabolise progesterone is perhaps not
surprising as both the adrenal and the testis share a common
steroidogenic pathway.
The two major pathways of testicular steroidogenesis in the
rat (Chubb, 1979b) are:
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i) Pregnenelone —► 17-hydroxypregnenelone > 17-hydroxy-
progesterone » androstenedione > testosterone. This pathway
accounts for up to 72$ of the testosterone stecreted by the rat
testis with the rate-limiting step residing in the conversion of
pregnenelone > 17-hydroxypregnenelone.
ii) Pregnenelone —► progesterone » 17-hydroxy-
progesterone » androstenedione —► testosterone. This pathway
accounts for up to 57$ of the testosterone secreted by the rat
testis with the rate-limiting step in this pathway is the
conversion of pregnenelone » progesterone.
Thus pregnenelone can be metabolised by the two pathways at
almost equal rates.
The two major pathways of adrenal steroidogenesis in the rat
are:
i) Pregnenelone » progesterone » 11-deoxycorticosterone
» corticosterone —(aldosterone).
ii) Pregnenelone » 17-hydroxypregnenelone » 17pV
hydroxyprogesterone.
4.3: Conclusions
The significance of these in vitro findings is to provide
evidence that:
i) only isolated testicular and not adrenal cells secrete
androgens in any significant quantity.
ii) the adrenal secretion of steroid precursors and the





iii) the concentrations of steroids achieved in the







The adrenal secretion of progesterone and corticosterone act
as two important external signals to the hypothalamic-pituitary-
testicular axis (Fig 5.1):
i) The adrenal synthesis of progesterone and its subsequent
secretion into the circulation provides a positive signal for
testicular steroidogenesis and both Leydig and Sertoli cells are
probably involved in the metabolism of progesterone to
testosterone. However, the ability of progesterone to stimulate
testicular steroidogenesis appears to be restricted to definite
periods in testicular maturation - in fetal life, before and after
puberty. The adrenal secretion of progesterone and its conversion
to testosterone by the cytoplasm of the Leydig cell may provide an
alternative pathway for testosterone biosynthesis during the acute
phase of stress and mating.
ii) The adrenal secretion of corticosterone may provide an
important negative signal to testicular steroidogenesis by
inhibiting the anterior pituitary secretion of LH and may also have
direct effects on LH-receptors of the Leydig cells, inhibiting
testicular steroidogenesis directly. Whilst suppression of the
hypothalamic-pituitary-testicular axis may be achieved with
pharmacological levels of glucocorticoids, this may also be
achieved with physiological levels (Vreeburg, 1984). The
administration of ACTH to intact rats increases the adrenal
secretion of both progesterone and corticosterone (achieving plasma
corticosterone levels of approximately 300 ng/ml) and depresses
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Figure 5.1; The adrenal gland provides two important external
signals that may modify the internal signals of the hypothalamic
pituitary-testicular axis in the rat.
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plasma testosterone levels.
5.2: Evidence for adrenal m gonad interactions In the female
rat.
So far this thesis has largely concentrated upon the influence
of the adrenal upon gonadal function in the male rat. Yet there is
evidence that the adrenal may affect the function of the female
reproductive system in the rat. In the female, the adrenal gland
appears to be necessary for the development of normal puberty, the
development of vaginal opening, ovulation, lactation, pregnancy and
the quality of the fetus (Thoman, 1970; for reviews see Ramaley,
1974; Ramaley, 1975; MacFarland, 1977).
Much of the information concerning the influence of the
adrenal gland on female reproductive function has been derived from
the effects of adrenalectomy on these parameters. It is quite
clear that the hormonal response to adrenalectomy in female rats is
very different from their male counterparts. In females,
adrenalectomy enhances the castration-induced rise of the anterior
pituitary secretion of LH, and inhibits the secretion of FSH
(Zanisi, 1983). It would appear that a signal from the adrenal
gland inhibits the anterior pituitary secretion of LH and loss of
this signal facilitates the post-castration rise in serum LH
concentrations.
The administration of ACTH to intact prepubertal females also
delays the onset of puberty and is associated with increased plasma
progesterone and depressed plasma LH levels, implying that
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progesterone is the signal inhibiting ovarian function. Whilst
adrenalectomy achieves a similar delay in the onset of puberty,
plasma concentrations of eorticosterone and progesterone were
undetectable, suggesting that the mechanism of delayed puberty in
these animals was different to that of their intact counterparts.
Adrenalectomy may therefore delay the onset of puberty in female
rats by non-specific means.
The fluctuations of LH, oestrogen and progesterone during the
oestrus cycle is well characterised (for review see Kalra, 1977):
i) Secretion of LH: Low mean levels of LH are found in the
blood at oestrus, increasing from oestrus through to dioestrus I
due to increased pulse frequency and amplitude, then decreasing
from dioestrus II through to the morning of pro-oestrus due to a
decrease in pulse amplitude. During the afternoon of pro-oestrus
the pre-ovulatory surge of LH is characterised by an increase in
both amplitude and frequency of secretion similar to that seen only
in the castrated female rat. Oestrogen is the primary ovarian
signal responsible for the preovulatory release of LH and is
mediated by a complex interaction acting at the level of the
anterior pituitary gonadotroph and also possibly at the level of
the hypothalamus. The effect of ovarian progesterone is probably
mediated by its direct effect upon the pituitary gland although
some evidence suggests that this may be centrally mediated. Under
conditions of steady oestrogen concentrations progesterone
stimulates LH secretion in low doses and inhibits in higher doses
(McPherson, 1979).
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ii) Sex steroids: The oestrus phase of the cycle is a
relatively quiescent period for ovarian steroid production but
oestrogen and progesterone secretion increase from dioestrus I
until the noon of dioestrus II, when ovarian progesterone secretion
wanes, and oestrogen secretion gradually increases culminating in a
rapid peak around the time of the pre-ovulatory surge in LH
secretion (pro-oestrus). Ovarian progesterone acts to restrain
oestrogen secretion as the ovarian follicles grow from dioestrus I
through to dioestrus II. Blood levels of progesterone must remain
low during the later phase of dioestrus to allow the positive
feedback of oestrogen effect on LH secretion. Similarly the
adrenal secretion of progesterone and other precursor steroids may
be important in modulating LH release. Both ACTH and deoxy¬
corticosterone have been shown to stimulate the surge of
gonadotrophins underlying ovulation (Kraulis, 1978; McPherson,
1979).
The fundamental difference in the effect of these steroids on
the anterior pituitary secretion of gonadotrophin in the sexes
probably depends upon the sexual differentiation of the
hypothalamus (Brown-Grant, 1974; Aiyer, 1976; Fink, 1977; for
review see Kalra, 1983).
5.3: Evidence for adrenal » gonad interactions in the male of
other animal species.
i) In the rabbit, the acute administration of ACTH to intact
animals results in a rapid rise of plasma corticosteroid levels
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and a biphasic response of plasma testosterone levels - an initial
rise is followed by a fall over a period when elevation of plasma
corticosteroids is sustained (Pitzel, 1984). This response is not
seen in castrated rabbits.
ii) In the pig, the acute administration of ACTH to intact
boars results in a rapid rise in plasma corticosteroid,
progesterone and testosterone concentrations that is not seen in
their adrenalectomised counterparts or in castrated boars (barrows)
(Liptrap, 1975; Hahmeier, 1980; Juniewicz, 1981; Juniewicz, 1984).
Furthermore, this response is not mediated via LH secretion
(Juniewicz, 1981). In contrast, the chronic administration of ACTH
suppresses plasma testosterone levels indirectly by inhibiting
anterior pituitary gonadotrophs (Liptrap, 1968; Liptrap, 1975).
Plasma concentrations of corticosteroids and testosterone rise
sharply in boars exposed to another aggressive boar or during
copulation with an oestrous sow. The administration of metyrapone
reduces this response without interfering directly with testicular
steroidogenesis (Liptrap, 1978). However, the administration of
lysine-vasopressin failed to mimic the results achieved by the
administration of ACTH despite inducing a rise in plasma cortico¬
steroid concentrations. Nevertheless, it is tempting to speculate
that stress-induced elevation of plasma testosterone concentrations
is important in the sexual and aggressive behaviour of these
animals.
These studies indicate a strong relationship between the
adrenal secretion of corticosteroids and testicular steroidogenesis
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that is independent of anterior pituitary LH secretion. However,
there is conflicting data on the results of the acute
administration of corticosteroids to these animals. The acute
administration of Cortisol, in a dose achieving physiological
plasma levels, results in a rapid rise in plasma testosterone
levels (Liptrap, 1975). However, this observation has not been
confirmed by other investigators (Juniewicz, 1981). In contrast,
the administration of pharmacological doses of glucocorticoid
suppresses testicular steroidogenesis by inhibition of LH-secretion
(Liptrap, 1968).
iii) In dogs it has been demonstrated that perfusion of the
testis in situ with the animal's own adrenal venous blood resulted
in a greater secretion of dehydroepiandrosterone and testosterone
than when the testis was perfused with the animal's own peripheral
arterial blood (Wassermann, 1969). Since the canine adrenal does
not secrete significant amounts of either dehydroepiandrosterone or
testosterone it is likely that an adrenal precursor such as
progesterone stimulates testicular steroidogenesis.
5.4; Evidence for adrenal » gonad interactions in the human
Recent studies have attempted to determine whether the adrenal
secretion of corticosteroids has any influence over gonadal
function in human health and disease.
i) In men acute stress increases the concentrations of ACTH,
Cortisol, androstenedione and dehyroepiandrosterone but depresses
the concentration of testosterone in the blood. The fall in plasma
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testosterone is probably mediated by the acute rise in plasma
Cortisol concentrations since the acute administration of
hydrocortisone achieves a similar decline (Cumming, 1983).
The chronic administration of ACTH to normal males results in
increased secretion of Cortisol, androstenedione and a profound
suppression of testosterone secretion without influencing plasma LH
levels (Rivarola, 1966; Beitins, 1973; Smals 1974; Irvine, 1974).
Similarly chronic stress, illness, surgery under general
anaesthesia and vigorous exercise are also associated with marked
decreases in plasma testosterone concentrations (Wang, 1978a; Wang
1978b; for review see Cumming, 1983). It would appear that the
adrenal secretion of corticosteroids plays a major inhibitory role
over the hypothalamic-pituitary-testicular axis in normal man.
However, the administration of dehydroepiandrosterone sulphate
to boys with familial cytomegalic adrenocortical hypoplasia
significantly increases plasma levels of dehydroepiandrosterone,
its sulphate, androstenedione and testosterone concentrations
(Cohen, 1982). Whether these plasma levels reflect direct
stimulation of testicular steroidogenesis by dehydroepiandrosterone
or its peripheral conversion is unknown. The testis is the major
contributor to plasma testosterone concentrations (for review see
Brooks, 1984). The respective daily secretion rates of androgen by
the human adrenal and testis are 24 and 0.7 pmol for dehydroepi¬
androsterone, 7 and 0.7 pmol for androstenedione and 0.04 and 24
jumol for testosterone. It is possible that only the suppressed
testis is capable of responding to the administration of steroid
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precursors.
ii) In women a great deal of attention has been focused on
the possibility that the adrenal gland may profoundly affect the
ovary in the polycystic ovarian syndrome (for review see Yen, 1980
and Brooks, 1984). The clinical mainifestations of this disorder
are the continuation of postmenarchal menstrual irregularity and
progressive development of hirsutism, obesity, infertility and the
development of polycystic ovaries. In the blood, the
characteristic features are raised plasma LH and depressed plasma
FSH levels in association with raised plasma androgen
concentrations (dehydroepiandrosterone, androstenedione and testo¬
sterone) and raised levels of plasma oestrogen (in particular an
increased ratio of oestrone : oestradiol).
Although it is well established that plasma androgen levels
are raised in this condition, the source of these raised levels has
been the centre of a great deal of controversy. Venous
catheterisation studies have demonstrated an adrenal source for
dehydroepiandrosterone and an ovarian source for androstenedione
and testosterone. This is confirmed by the ready suppressibility
of plasma dehydroepiandrosterone but not plasma androstenedione and
testosterone levels by the administration of pharmacological doses
of dexamethasone (Lachelin, 1982). Thus polycystic ovaries are
probably the source of excessive amounts of androstenedione which
is converted by peripheral conversion to both oestrone and
testosterone. The former stimulates LH and suppresses FSH
secretion leading to a vicious cycle of chronic anovulation, the
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development of polycystic ovaries and continuing increased androgen
secretion. The latter leads to hirsutism and obesity (Yen, 1980).
However, adrenal scintigraphy has shown that patients with
polycystic ovaries have increased adrenocortical function (Gross,
1986). Furthermore, plasma pregnenelone, progesterone, 17-
hydroxyprogesterone and dehydroepiandrosterone concentrations are
significantly increased in response to ACTH in patients with
polycystic ovaries (Lachelin, 1979) as are the levels of 11-
deoxycortisol, androstenedione and testosterone in response to
metyrapone (for review see McKenna, 1985; Loughlin, 1986).
The conclusion of these studies is that there appear to be two
major abnormalities in the polycystic ovarian syndrome:
i) abnormal adrenal function with the increased secretion of
steroid precursors.
ii) abnormal polycystic ovaries that secrete abormal amounts
of androstenedione.
A unifying hypothesis to explain this syndrome is that an
abnormal adrenarche with increased secretion of adrenal androgens
is essential in the initiation of of the abnormal gonadotrophin
response and the subsequent development of polycystic ovaries. In
the early stages of this condition suppression of the hypothalamic-
pituitary-adrenal axis with dexamethasone will restore the abnormal
hormonal profiles to normal and initiate normal menstrual function.
However, as androgen production from the ovary increases in
response to the abnormal gonadotrophin pattern, suppressibility of
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